{"data":{"filter_options":{"titles":[{"name":"Managing Partner Atlanta Office","value":"Managing Partner Atlanta Office"},{"name":"Partner","value":"Partner"},{"name":"Partner / Head of Pro Bono","value":"Partner / Head of Pro Bono"},{"name":"Partner / Chief Operating Officer","value":"Partner / Chief Operating Officer"},{"name":"Partner / General Counsel","value":"Partner / General Counsel"},{"name":"Partner / Dir. E-Discovery Ops","value":"Partner / Dir. E-Discovery Ops"},{"name":"Partner / Chairman, Saudi Arabia Practice","value":"Partner / Chairman, Saudi Arabia Practice"},{"name":"K\u0026S Talent Partner","value":"K\u0026S Talent Partner"},{"name":"Partner / Chief Human Resources Officer","value":"Partner / Chief Human Resources Officer"},{"name":"Chairman","value":"Chairman"},{"name":"Senior Counsel","value":"Senior Counsel"},{"name":"Associate Director, E-Discovery Operations","value":"Associate Director, E-Discovery Operations"},{"name":"Counsel","value":"Counsel"},{"name":"Senior Associate","value":"Senior Associate"},{"name":"Associate","value":"Associate"},{"name":"Senior Attorney","value":"Senior Attorney"},{"name":"Senior Lawyer","value":"Senior Lawyer"},{"name":"Attorney","value":"Attorney"},{"name":"Senior Counsel and Policy Advisor","value":"Senior Counsel and Policy Advisor"},{"name":"Managing Director - Capital Solutions","value":"Managing Director - Capital Solutions"},{"name":"Senior Government Relations Advisor","value":"Senior Government Relations Advisor"},{"name":"Associate General Counsel","value":"Associate General Counsel"},{"name":"Senior Advisor","value":"Senior Advisor"},{"name":"Patent Agent","value":"Patent Agent"},{"name":"Consultant","value":"Consultant"},{"name":"Government Relations Advisor","value":"Government Relations Advisor"},{"name":"Chief of Lateral Partner Recruiting \u0026 Integration","value":"Chief of Lateral Partner Recruiting \u0026 Integration"},{"name":"Chief Financial Officer","value":"Chief Financial Officer"},{"name":"Chief Information Officer","value":"Chief Information Officer"},{"name":"Chief Revenue Officer","value":"Chief Revenue Officer"},{"name":"Chief Recruiting Officer","value":"Chief Recruiting Officer"},{"name":"Chief Lawyer Talent Development Officer","value":"Chief Lawyer Talent Development Officer"},{"name":"Chief Marketing Officer","value":"Chief Marketing Officer"},{"name":"Tax Consultant","value":"Tax Consultant"},{"name":"Director of Community Affairs","value":"Director of Community Affairs"},{"name":"Director of Facilities \u0026 Admin Operations","value":"Director of Facilities \u0026 Admin Operations"},{"name":"Senior Office Manager","value":"Senior Office Manager"},{"name":"Director of Operations","value":"Director of Operations"},{"name":"Pro Bono Deputy","value":"Pro Bono Deputy"},{"name":"Director of Office Operations","value":"Director of Office Operations"},{"name":"Director of Operations Europe","value":"Director of Operations Europe"},{"name":"Law Clerk","value":"Law Clerk"},{"name":"Deputy General Counsel","value":"Deputy General Counsel"}],"schools":[{"name":"(Commercial Law), in front of Monash University, Australia","value":3045},{"name":"Aberystwyth University","value":3004},{"name":"Albany Law School","value":2118},{"name":"American University Washington College of Law","value":3042},{"name":"American University, Washington College of Law","value":3024},{"name":"Appalachian School of Law","value":2891},{"name":"Ateneo de Manila University","value":2914},{"name":"Ave Maria School of Law","value":2892},{"name":"Baylor University School of Law","value":181},{"name":"Benjamin N. Cardozo School of Law","value":2619},{"name":"Binghamton University","value":3002},{"name":"Boston College Law School","value":245},{"name":"Boston University School of Law","value":247},{"name":"BPP Law School Leeds","value":2642},{"name":"BPP Law School London","value":2782},{"name":"BPP University","value":2984},{"name":"Brooklyn Law School","value":2705},{"name":"Cairo University, Law School","value":2962},{"name":"California Western School of Law","value":315},{"name":"Capital University Law School","value":327},{"name":"Case Western Reserve University School of Law","value":345},{"name":"Cecil C. Humphreys School of Law","value":2235},{"name":"Chapman University School of Law","value":377},{"name":"Charleston School of Law","value":2910},{"name":"City Law School, London","value":2998},{"name":"City Law School","value":2857},{"name":"Clark University","value":3006},{"name":"Cleveland-Marshall College of Law","value":426},{"name":"Columbia University School of International and Public Affairs","value":3008},{"name":"Columbia University School of Law","value":485},{"name":"Columbia University","value":3126},{"name":"Columbus School of Law, Catholic University of America","value":3010},{"name":"Columbus School of Law","value":350},{"name":"Concord Law School of Kaplan University","value":1026},{"name":"Cornell Law School","value":512},{"name":"Creighton University School of Law","value":518},{"name":"Creighton University","value":3025},{"name":"Cumberland School of Law","value":1759},{"name":"CUNY School of Law","value":2893},{"name":"David A. Clarke School of Law","value":2399},{"name":"Deakin University School of Law","value":2907},{"name":"DePaul University College of Law","value":565},{"name":"DePaul University College of Law","value":3060},{"name":"Dickinson School of Law","value":2719},{"name":"Drake University Law School","value":609},{"name":"Duke University School of Law","value":613},{"name":"Duquesne University School of Law","value":614},{"name":"Dwayne O. Andreas School of Law","value":173},{"name":"Edinburgh Law School","value":3160},{"name":"Emory University School of Law","value":659},{"name":"ESADE Business and Law School – Universidad Ramon Llull","value":3215},{"name":"Fachseminare von Fürstenberg","value":2918},{"name":"Faculté Libre de Droit, Université Catholique de Lille","value":3055},{"name":"Faculty of Law, University of Zagreb","value":2983},{"name":"Faculty of Law","value":2944},{"name":"Faculty of Law","value":3039},{"name":"Federal University of Rio de Janeiro","value":3022},{"name":"Federal University of Rio Grande do Sul School of Law (Brazil)","value":3062},{"name":"Florida A\u0026M University College of Law","value":699},{"name":"Florida Coastal School of Law","value":2894},{"name":"Florida International College of Law","value":707},{"name":"Florida State University College of Law","value":720},{"name":"Fordham University School of Law","value":722},{"name":"Franklin Pierce Law Center","value":734},{"name":"Friedrich-Schiller-Universität Jena","value":3015},{"name":"George Mason University School of Law","value":752},{"name":"George Washington University Law School","value":753},{"name":"Georgetown University Law Center","value":755},{"name":"Georgia State University College of Law","value":761},{"name":"Ghent Law School","value":2793},{"name":"Golden Gate University School of Law","value":770},{"name":"Gonzaga University School of Law","value":772},{"name":"Graduate Institute of International and Development Studies, Geneva","value":2997},{"name":"Hamline University School of Law","value":811},{"name":"Harvard Law School","value":824},{"name":"Hebrew University of Jerusalem Faculty of Law","value":2994},{"name":"Hofstra University School of Law","value":858},{"name":"Howard University School of Law","value":872},{"name":"Huazhong University of Science and Technology","value":3016},{"name":"Humboldt University of Berlin","value":3012},{"name":"Indiana University School of Law","value":2711},{"name":"Indiana University School of Law","value":890},{"name":"International Association of Privacy Professionals","value":3009},{"name":"J. Reuben Clark Law School","value":262},{"name":"Jacob D. Fuchsberg Law Center","value":2084},{"name":"James Cook University of North Queensland","value":3034},{"name":"Jean Moulin University Lyon 3, France","value":2938},{"name":"Johns Hopkins Bloomberg School of Public Health","value":2992},{"name":"Justus-Liebig-Universität Gießen Rechtswissenschaft (Germany)","value":3063},{"name":"Kansas City School of Law","value":2247},{"name":"Keio University","value":2968},{"name":"Kent College of Law","value":883},{"name":"Kline School of Law","value":611},{"name":"KU Leuven","value":3007},{"name":"Levin College of Law","value":2189},{"name":"Lewis and Clark Law School","value":1089},{"name":"Liberty University School of Law","value":1094},{"name":"Lincoln College of Law","value":2253},{"name":"LL.M. in International Crime and Justice UNICRI","value":2937},{"name":"Loyola Law School","value":2895},{"name":"Loyola University Chicago School of Law","value":1135},{"name":"Loyola University New Orleans College of Law","value":1136},{"name":"Marquette University Law School","value":1176},{"name":"McGeorge School of Law","value":2402},{"name":"McGill University","value":2659},{"name":"Melbourne Law School","value":2899},{"name":"Mercer University Walter F. George School of Law","value":1221},{"name":"Mexico Autonomous Institute of Technology","value":2996},{"name":"Michael E. Moritz College of Law","value":2728},{"name":"Michigan State University College of Law","value":1245},{"name":"Mississippi College School of Law","value":1285},{"name":"Moscow State University","value":2815},{"name":"National and Kapodistrian University of Athens","value":3032},{"name":"National Law University Jodhpur","value":3020},{"name":"National University of Singapore, Faculty of Law","value":2662},{"name":"New England School of Law","value":2886},{"name":"New York Law School","value":1403},{"name":"New York University School of Law","value":1406},{"name":"Norman Adrian Wiggins School of Law","value":323},{"name":"North Carolina Central University School of Law","value":1417},{"name":"Northeastern University School of Law","value":1430},{"name":"Northern Illinois University College of Law","value":1432},{"name":"Northwestern Pritzker School of Law","value":1451},{"name":"Notre Dame Law School","value":2278},{"name":"Ohio Northern University Law School","value":3036},{"name":"Oklahoma City University School of Law","value":1487},{"name":"Osgoode Hall Law School","value":3124},{"name":"Pace University School of Law","value":1516},{"name":"Panteion University","value":3033},{"name":"Paul M. Hebert Law Center","value":2713},{"name":"Pennsylvania State University, Dickinson School of Law","value":1562},{"name":"Pepperdine University School of Law","value":1570},{"name":"Pettit College of Law","value":1473},{"name":"Pontificia Universidad Catolica de Chile","value":3203},{"name":"Pontificia Universidad Catolica del Peru","value":3011},{"name":"Pontificia Universidad Javeriana","value":3013},{"name":"Pontificia Universidade Catolica de Sao Paulo","value":3095},{"name":"Prince Sultan University College of Law","value":3167},{"name":"Queens College, Cambridge","value":3003},{"name":"Quinnipiac University School of Law","value":1626},{"name":"Ralph R. Papitto School of Law","value":1686},{"name":"Regent University School of Law","value":1649},{"name":"Rice University","value":3043},{"name":"Ruprecht-Karls-Universität Heidelberg","value":3049},{"name":"Rutgers University School of Law-Newark","value":1699},{"name":"Rutgers University School of Law","value":1697},{"name":"S.J. Quinney College of Law","value":2408},{"name":"Saint Louis University School of Law","value":1732},{"name":"Salmon P. Chase College of Law","value":1433},{"name":"Sandra Day O'Connor College of Law","value":103},{"name":"Santa Clara University School of Law","value":1771},{"name":"Seattle University School of Law","value":1787},{"name":"Seton Hall University School of Law","value":1790},{"name":"Shepard Broad Law Center","value":1460},{"name":"South Texas College of Law","value":2721},{"name":"Southern Illinois University School of Law","value":1849},{"name":"Southern Methodist University Dedman School of Law","value":1852},{"name":"Southern University Law Center","value":1857},{"name":"Southwestern Law School","value":1876},{"name":"St. John's University School of Law","value":2724},{"name":"St. Mary's University School of Law","value":1896},{"name":"St. Thomas University School of Law","value":1746},{"name":"Stanford Law School","value":1904},{"name":"Stetson University College of Law","value":1910},{"name":"Sturm College of Law","value":2184},{"name":"Suffolk University Law School","value":1921},{"name":"Syracuse University College of Law","value":1956},{"name":"Temple University Beasley School of Law","value":1974},{"name":"Texas A\u0026M School of Law","value":1980},{"name":"Texas Tech University School of Law","value":1994},{"name":"Texas Wesleyan University School of Law","value":1996},{"name":"The College of Law Australia","value":3091},{"name":"The College of Law, London","value":2935},{"name":"The John Marshall Law School","value":2034},{"name":"The Judge Advocate General's Legal Center and School","value":2896},{"name":"The Ohio State University Moritz College of Law","value":2990},{"name":"The University of Akron School of Law","value":2143},{"name":"The University of Alabama School of Law","value":2045},{"name":"The University of Birmingham, U.K.","value":2796},{"name":"The University of Iowa College of Law","value":2206},{"name":"The University of Texas School of Law","value":2055},{"name":"The University of Tulsa College of Law","value":2407},{"name":"Thomas Jefferson School of Law","value":685},{"name":"Thomas M. Cooley Law School","value":2729},{"name":"Thurgood Marshall School of Law","value":1992},{"name":"Tianjin University of Commerce","value":2995},{"name":"Tulane University Law School","value":2113},{"name":"UC Davis School of Law","value":2160},{"name":"UCLA School of Law","value":2162},{"name":"Universidad Católica de Honduras","value":2916},{"name":"Universidad Francisco Marroquin","value":3090},{"name":"Universidad Panamericana","value":2904},{"name":"Universidad Torcuato di Tella","value":3035},{"name":"Universidade de São Paulo, Faculdade de Direito","value":3028},{"name":"Universidade Presbiteriana Mackenzie","value":2977},{"name":"Università Commerciale Luigi Bocconi","value":3135},{"name":"University at Buffalo Law School","value":1928},{"name":"University College Dublin Law School","value":2900},{"name":"University of Alberta Faculty of Law","value":3088},{"name":"University of Amsterdam","value":2980},{"name":"University of Arizona, James E. Rogers College of Law","value":2149},{"name":"University of Arkansas School of Law","value":2154},{"name":"University of Baltimore School of Law","value":2156},{"name":"University of California College of the Law","value":3196},{"name":"University of California Hastings College of Law","value":2158},{"name":"University of California Irvine School of Law","value":2161},{"name":"University of California, Berkeley, School of Law","value":2159},{"name":"University of California, Davis","value":3019},{"name":"University of Cambridge, U.K","value":2991},{"name":"University of Canterbury","value":2981},{"name":"University of Central Florida","value":3027},{"name":"University of Chester Law School","value":3005},{"name":"University of Chicago Law School","value":2174},{"name":"University of Chicago","value":3038},{"name":"University of Cincinnati College of Law","value":2175},{"name":"University of Colorado School of Law","value":2177},{"name":"University of Connecticut School of Law","value":2180},{"name":"University of Dayton School of Law","value":2182},{"name":"University of Detroit Mercy School of Law","value":2185},{"name":"University of East Anglia","value":3000},{"name":"University of Florida, Levin College of Law","value":3188},{"name":"University of Georgia School of Law","value":2190},{"name":"University of Houston Law Center","value":2197},{"name":"University of Hull","value":3040},{"name":"University of Idaho College of Law","value":2201},{"name":"University of Illinois College of Law","value":2204},{"name":"University of Kansas School of Law","value":2208},{"name":"University of Kentucky College of Law","value":2210},{"name":"University of La Verne College of Law","value":2211},{"name":"University of Law, London","value":2999},{"name":"University of Lethbridge","value":3030},{"name":"University of Louisville Brandeis School of Law","value":2214},{"name":"University of Maine School of Law","value":2391},{"name":"University of Maryland School of Law","value":2224},{"name":"University of Miami School of Law","value":2236},{"name":"University of Michigan Law School","value":2237},{"name":"University of Minnesota Law School","value":2243},{"name":"University of Mississippi School of Law","value":2244},{"name":"University of Missouri School of Law","value":2246},{"name":"University of Montana School of Law","value":2048},{"name":"University of Nebraska College of Law","value":2744},{"name":"University of New Mexico School of Law","value":2262},{"name":"University of North Carolina School of Law","value":2266},{"name":"University of North Dakota School of Law","value":2271},{"name":"University of Oklahoma Law Center","value":2747},{"name":"University of Oregon School of Law","value":2281},{"name":"University of Pennsylvania Law School","value":2282},{"name":"University of Pittsburgh School of Law","value":2354},{"name":"University of Richmond School of Law","value":2370},{"name":"University of San Diego School of Law","value":2377},{"name":"University of San Francisco School of Law","value":2378},{"name":"University of South Carolina School of Law","value":2750},{"name":"University of South Dakota School of Law","value":2387},{"name":"University of Southern California Gould School of Law","value":3051},{"name":"University of St. Thomas School of Law","value":2751},{"name":"University of Sydney Law School","value":3031},{"name":"University of Tennessee College of Law","value":2051},{"name":"University of the West of England, Bristol","value":3001},{"name":"University of Toledo College of Law","value":2406},{"name":"University of Toronto","value":2912},{"name":"University of Utah","value":3026},{"name":"University of Virginia School of Law","value":2410},{"name":"University of Washington School of Law","value":2412},{"name":"University of Wisconsin Law School","value":2419},{"name":"University of Wyoming College of Law","value":2429},{"name":"University of Zürich","value":3037},{"name":"University Paris Dauphine","value":2976},{"name":"University Paris II Assas","value":2975},{"name":"University Paris II Assas","value":3052},{"name":"USC Gould School of Law","value":2389},{"name":"Utrecht University","value":3085},{"name":"Valparaiso University School of Law","value":2441},{"name":"Vanderbilt University School of Law","value":2442},{"name":"Vermont Law School","value":2451},{"name":"Villanova University School of Law","value":2454},{"name":"Wake Forest University School of Law","value":2471},{"name":"Washburn University School of Law","value":2482},{"name":"Washington and Lee University School of Law","value":2484},{"name":"Washington College of Law","value":61},{"name":"Washington University in St. Louis School of Law","value":2489},{"name":"Wayne State University Law School","value":2493},{"name":"West Virginia University College of Law","value":2517},{"name":"Western New England College School of Law","value":2528},{"name":"Western State College of Law","value":2897},{"name":"Wharton School of Business","value":3044},{"name":"Whittier Law School","value":2564},{"name":"Widener University Delaware Law School","value":2569},{"name":"Willamette University College of Law","value":2573},{"name":"William \u0026 Mary Law School","value":462},{"name":"William H. Bowen School of Law","value":2150},{"name":"William Mitchell College of Law","value":2758},{"name":"William S. Boyd School of Law","value":2256},{"name":"William S. Richardson School of Law","value":2195},{"name":"Wilmington University","value":2993},{"name":"Yale Law School","value":2605}],"offices":[{"name":"Abu Dhabi","value":13},{"name":"Atlanta","value":1},{"name":"Austin","value":12},{"name":"Brussels","value":23},{"name":"Charlotte","value":8},{"name":"Chicago","value":21},{"name":"Dallas","value":28},{"name":"Denver","value":22},{"name":"Dubai","value":6},{"name":"Frankfurt","value":9},{"name":"Geneva","value":15},{"name":"Houston","value":4},{"name":"London","value":5},{"name":"Los Angeles","value":19},{"name":"Miami","value":25},{"name":"New York","value":3},{"name":"Northern Virginia","value":24},{"name":"Paris","value":14},{"name":"Riyadh","value":27},{"name":"Sacramento","value":20},{"name":"San Francisco","value":10},{"name":"Silicon Valley","value":11},{"name":"Singapore","value":16},{"name":"Sydney","value":26},{"name":"Tokyo","value":18},{"name":"Washington, D.C.","value":2}],"capabilities":[{"name":"Corporate, Finance and Investments","value":"cg-1"},{"name":"Activist Defense","value":72},{"name":"Capital Markets","value":26},{"name":"Construction and Procurement","value":40},{"name":"Corporate Governance","value":27},{"name":"Emerging Companies and Venture Capital","value":80},{"name":"Employee Benefits and Executive Compensation","value":28},{"name":"Energy and Infrastructure Projects","value":35},{"name":"Financial Restructuring","value":10},{"name":"Fund Finance","value":134},{"name":"Global Human Capital and Compliance ","value":121},{"name":"Investment Funds and Asset Management","value":78},{"name":"Leveraged Finance","value":29},{"name":"Mergers and Acquisitions (M\u0026A)","value":32},{"name":"Middle East and Islamic Finance and Investment","value":31},{"name":"Private Equity","value":33},{"name":"Public Companies","value":126},{"name":"Real Estate","value":36},{"name":"Structured Finance and Securitization","value":82},{"name":"Tax","value":37},{"name":"Technology Transactions","value":115},{"name":"Government Matters","value":"cg-2"},{"name":"Antitrust","value":1},{"name":"Data, Privacy and Security","value":6},{"name":"Environmental, Health and Safety","value":71},{"name":"FDA and Life Sciences","value":21},{"name":"Government Advocacy and Public Policy","value":23},{"name":"Government Contracts","value":116},{"name":"Healthcare","value":24},{"name":"Innovation Protection","value":135},{"name":"International Trade","value":25},{"name":"National Security and Corporate Espionage","value":110},{"name":"Securities Enforcement and Regulation","value":20},{"name":"Special Matters and Government Investigations","value":11},{"name":"Trial and Global Disputes","value":"cg-3"},{"name":"Antitrust ","value":129},{"name":"Appellate, Constitutional and Administrative Law","value":2},{"name":"Bankruptcy and Insolvency Litigation","value":38},{"name":"Class Action Defense","value":3},{"name":"Commercial Litigation","value":5},{"name":"Corporate and Securities Litigation","value":19},{"name":"E-Discovery","value":7},{"name":"Global Construction and Infrastructure Disputes","value":4},{"name":"Innovation Protection","value":136},{"name":"Intellectual Property","value":13},{"name":"International Arbitration and Litigation","value":14},{"name":"Labor and Employment","value":15},{"name":"Product Liability","value":17},{"name":"Professional Liability","value":18},{"name":"Toxic \u0026 Environmental Torts","value":16},{"name":"Industries / Issues","value":"cg-4"},{"name":"Artificial Intelligence (AI) and Machine Learning","value":133},{"name":"Automotive, Transportation and Mobility","value":106},{"name":"Buy American","value":124},{"name":"Crisis Management","value":111},{"name":"Doing Business in Latin America","value":132},{"name":"Energy Transition","value":131},{"name":"Energy","value":102},{"name":"Environmental Agenda","value":125},{"name":"Environmental, Social and Governance (ESG)","value":127},{"name":"Financial Services","value":107},{"name":"Focus on Women's Health","value":112},{"name":"Food and Beverage","value":105},{"name":"Higher Education","value":109},{"name":"Life Sciences and Healthcare","value":103},{"name":"Russia/Ukraine","value":128},{"name":"Special Purpose Acquisition Companies (SPACs)","value":123},{"name":"Technology","value":118}]},"title_id":null,"school_id":null,"office_id":null,"capability_id":"21","extra_filter_id":null,"extra_filter_type":null,"q":null,"starts_with":"K","per_page":12,"people":[{"id":426547,"version":1,"owner_type":"Person","owner_id":4105,"payload":{"bio":"\u003cp\u003eBrandon Keel is a partner in the firm\u0026rsquo;s Business Litigation Group, where he represents clients in a variety of complex commercial litigation, focusing primarily on class actions, securities litigation, and other shareholder disputes. Brandon has represented clients through all stages of litigation in a broad array of commercial matters, including securities and consumer class actions, shareholder derivative lawsuits, contract disputes, post-closing M\u0026amp;A disputes, and business torts.\u0026nbsp;[[--readmore--]]\u003c/p\u003e\n\u003cp\u003eBefore joining King \u0026amp; Spalding, Brandon was a litigation associate at Skadden, Arps, Slate, Meagher \u0026amp; Flom LLP, where he represented a number of Fortune 500 companies in high-stakes commercial litigation. During his time at Skadden, he helped secure dismissals of numerous putative consumer class action lawsuits against one of the nation\u0026rsquo;s leading food and beverage companies. He also represented clients in substantial litigation arising out of the financial crisis.\u003c/p\u003e\n\u003cp\u003eBrandon has served on the firm\u0026rsquo;s hiring committee and is active in the firm\u0026rsquo;s efforts to recruit new attorneys. He is a member of the Georgia and Illinois bars, as well as the Atlanta Bar Association.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003ePublications\u003c/strong\u003e\u003c/p\u003e\n\u003cul\u003e\n\u003cli\u003e\u003cem\u003eCFPB Proposes Rule Prohibiting Class Action Waivers And Requiring Reporting Of Arbitration Information\u003c/em\u003e, Client Alert, May 11, 2016.\u003cbr /\u003e\u003cbr /\u003e\u003c/li\u003e\n\u003cli\u003e\u003cem\u003eProfiting Under the Veil of Compensation: Wills v. Foster and the Application of the Collateral Source Rule to Medicare and Medicaid\u003c/em\u003e, 58 DePaul L. Rev. 789 (2009)\u003c/li\u003e\n\u003c/ul\u003e\n\u003cp\u003e\u0026nbsp;\u003c/p\u003e","slug":"brandon-keel","email":"bkeel@kslaw.com","phone":null,"matters":["\u003cp\u003eRepresenting SCANA Corporation in various litigation matters arising out of the abandonment of SCANA\u0026rsquo;s new nuclear power development at the V.C. Summer nuclear station in South Carolina, including the defense of ratepayer class actions, securities class action litigation, shareholder derivative lawsuits, and a regulatory proceeding in which SCANA achieved approval for a proposed $14.6 billion merger with Dominion Energy.\u003c/p\u003e","\u003cp\u003eRepresenting Equifax, Inc. in securities class action litigation and related government investigations arising out of the data breach announced in September 2017.\u003c/p\u003e","\u003cp\u003eRepresenting Quorum Health Corporation, an owner and operator of acute care hospitals, and its former officers in defense of securities class action and derivative litigation relating to Quorum\u0026rsquo;s spin-off from its former parent company.\u003c/p\u003e","\u003cp\u003eRepresenting U.S. Xpress Enterprises, Inc., a large truckload carrier, and its directors and officers in securities class action litigation relating to the company\u0026rsquo;s 2018 initial public offering.\u003c/p\u003e","\u003cp\u003eRepresenting Tivity Health, Inc., a provider of health and fitness improvement programs, and its directors and officers in securities class action and derivative litigation.\u003c/p\u003e","\u003cp\u003eRepresenting Acadia Healthcare Company, Inc., an owner and operater of behavioral healthcare facilities, and its directors and officers in securities class action litigation.\u003c/p\u003e","\u003cp\u003eRepresenting Aeterna Zentaris, Inc., a biopharmaceutical company, and certain of its former officers in securities class action litigation arising out of the FDA\u0026rsquo;s rejection of the company\u0026rsquo;s New Drug Application.\u003c/p\u003e","\u003cp\u003eRepresenting a leading company in the payment processing industry in connection with class action litigation brought on behalf of merchants.\u003c/p\u003e","\u003cp\u003eRepresented an international airline in defense of a commercial dispute for alleged breach of contract.\u003c/p\u003e","\u003cp\u003eRepresented one of the world\u0026rsquo;s leading food and beverage companies in defense of various consumer class action litigation.\u003c/p\u003e"],"taggings":{"tags":[],"meta_tags":[]},"expertise":[{"id":3,"guid":"3.capabilities","index":0,"source":"capabilities"},{"id":5,"guid":"5.capabilities","index":1,"source":"capabilities"},{"id":19,"guid":"19.capabilities","index":2,"source":"capabilities"},{"id":21,"guid":"21.capabilities","index":3,"source":"capabilities"},{"id":74,"guid":"74.capabilities","index":4,"source":"capabilities"},{"id":1157,"guid":"1157.smart_tags","index":5,"source":"smartTags"},{"id":1204,"guid":"1204.smart_tags","index":6,"source":"smartTags"}],"is_active":true,"last_name":"Keel","nick_name":"Brandon","clerkships":[],"first_name":"Brandon","title_rank":9999,"updated_by":202,"law_schools":[{"id":565,"meta":{"degree":"J.D.","honors":"summa cum laude, Order of the Coif","is_law_school":1,"graduation_date":"2009-01-01 00:00:00 UTC"},"order":1,"pin_order":null,"pin_expiration":null}],"middle_name":"R.","name_suffix":"","recognitions":null,"linked_in_url":null,"seodescription":null,"primary_title_id":15,"translated_fields":{"en":{"bio":"\u003cp\u003eBrandon Keel is a partner in the firm\u0026rsquo;s Business Litigation Group, where he represents clients in a variety of complex commercial litigation, focusing primarily on class actions, securities litigation, and other shareholder disputes. Brandon has represented clients through all stages of litigation in a broad array of commercial matters, including securities and consumer class actions, shareholder derivative lawsuits, contract disputes, post-closing M\u0026amp;A disputes, and business torts.\u0026nbsp;[[--readmore--]]\u003c/p\u003e\n\u003cp\u003eBefore joining King \u0026amp; Spalding, Brandon was a litigation associate at Skadden, Arps, Slate, Meagher \u0026amp; Flom LLP, where he represented a number of Fortune 500 companies in high-stakes commercial litigation. During his time at Skadden, he helped secure dismissals of numerous putative consumer class action lawsuits against one of the nation\u0026rsquo;s leading food and beverage companies. He also represented clients in substantial litigation arising out of the financial crisis.\u003c/p\u003e\n\u003cp\u003eBrandon has served on the firm\u0026rsquo;s hiring committee and is active in the firm\u0026rsquo;s efforts to recruit new attorneys. He is a member of the Georgia and Illinois bars, as well as the Atlanta Bar Association.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003ePublications\u003c/strong\u003e\u003c/p\u003e\n\u003cul\u003e\n\u003cli\u003e\u003cem\u003eCFPB Proposes Rule Prohibiting Class Action Waivers And Requiring Reporting Of Arbitration Information\u003c/em\u003e, Client Alert, May 11, 2016.\u003cbr /\u003e\u003cbr /\u003e\u003c/li\u003e\n\u003cli\u003e\u003cem\u003eProfiting Under the Veil of Compensation: Wills v. Foster and the Application of the Collateral Source Rule to Medicare and Medicaid\u003c/em\u003e, 58 DePaul L. Rev. 789 (2009)\u003c/li\u003e\n\u003c/ul\u003e\n\u003cp\u003e\u0026nbsp;\u003c/p\u003e","matters":["\u003cp\u003eRepresenting SCANA Corporation in various litigation matters arising out of the abandonment of SCANA\u0026rsquo;s new nuclear power development at the V.C. Summer nuclear station in South Carolina, including the defense of ratepayer class actions, securities class action litigation, shareholder derivative lawsuits, and a regulatory proceeding in which SCANA achieved approval for a proposed $14.6 billion merger with Dominion Energy.\u003c/p\u003e","\u003cp\u003eRepresenting Equifax, Inc. in securities class action litigation and related government investigations arising out of the data breach announced in September 2017.\u003c/p\u003e","\u003cp\u003eRepresenting Quorum Health Corporation, an owner and operator of acute care hospitals, and its former officers in defense of securities class action and derivative litigation relating to Quorum\u0026rsquo;s spin-off from its former parent company.\u003c/p\u003e","\u003cp\u003eRepresenting U.S. Xpress Enterprises, Inc., a large truckload carrier, and its directors and officers in securities class action litigation relating to the company\u0026rsquo;s 2018 initial public offering.\u003c/p\u003e","\u003cp\u003eRepresenting Tivity Health, Inc., a provider of health and fitness improvement programs, and its directors and officers in securities class action and derivative litigation.\u003c/p\u003e","\u003cp\u003eRepresenting Acadia Healthcare Company, Inc., an owner and operater of behavioral healthcare facilities, and its directors and officers in securities class action litigation.\u003c/p\u003e","\u003cp\u003eRepresenting Aeterna Zentaris, Inc., a biopharmaceutical company, and certain of its former officers in securities class action litigation arising out of the FDA\u0026rsquo;s rejection of the company\u0026rsquo;s New Drug Application.\u003c/p\u003e","\u003cp\u003eRepresenting a leading company in the payment processing industry in connection with class action litigation brought on behalf of merchants.\u003c/p\u003e","\u003cp\u003eRepresented an international airline in defense of a commercial dispute for alleged breach of contract.\u003c/p\u003e","\u003cp\u003eRepresented one of the world\u0026rsquo;s leading food and beverage companies in defense of various consumer class action litigation.\u003c/p\u003e"]},"locales":["en"]},"secondary_title_id":null,"upload_assignments":{"headshot":[{"id":11795}]},"capability_group_id":3},"created_at":"2025-05-26T04:54:35.000Z","updated_at":"2025-05-26T04:54:35.000Z","searchable_text":"Keel{{ FIELD }}Representing SCANA Corporation in various litigation matters arising out of the abandonment of SCANA’s new nuclear power development at the V.C. Summer nuclear station in South Carolina, including the defense of ratepayer class actions, securities class action litigation, shareholder derivative lawsuits, and a regulatory proceeding in which SCANA achieved approval for a proposed $14.6 billion merger with Dominion Energy.{{ FIELD }}Representing Equifax, Inc. in securities class action litigation and related government investigations arising out of the data breach announced in September 2017.{{ FIELD }}Representing Quorum Health Corporation, an owner and operator of acute care hospitals, and its former officers in defense of securities class action and derivative litigation relating to Quorum’s spin-off from its former parent company.{{ FIELD }}Representing U.S. Xpress Enterprises, Inc., a large truckload carrier, and its directors and officers in securities class action litigation relating to the company’s 2018 initial public offering.{{ FIELD }}Representing Tivity Health, Inc., a provider of health and fitness improvement programs, and its directors and officers in securities class action and derivative litigation.{{ FIELD }}Representing Acadia Healthcare Company, Inc., an owner and operater of behavioral healthcare facilities, and its directors and officers in securities class action litigation.{{ FIELD }}Representing Aeterna Zentaris, Inc., a biopharmaceutical company, and certain of its former officers in securities class action litigation arising out of the FDA’s rejection of the company’s New Drug Application.{{ FIELD }}Representing a leading company in the payment processing industry in connection with class action litigation brought on behalf of merchants.{{ FIELD }}Represented an international airline in defense of a commercial dispute for alleged breach of contract.{{ FIELD }}Represented one of the world’s leading food and beverage companies in defense of various consumer class action litigation.{{ FIELD }}Brandon Keel is a partner in the firm’s Business Litigation Group, where he represents clients in a variety of complex commercial litigation, focusing primarily on class actions, securities litigation, and other shareholder disputes. Brandon has represented clients through all stages of litigation in a broad array of commercial matters, including securities and consumer class actions, shareholder derivative lawsuits, contract disputes, post-closing M\u0026amp;A disputes, and business torts. \nBefore joining King \u0026amp; Spalding, Brandon was a litigation associate at Skadden, Arps, Slate, Meagher \u0026amp; Flom LLP, where he represented a number of Fortune 500 companies in high-stakes commercial litigation. During his time at Skadden, he helped secure dismissals of numerous putative consumer class action lawsuits against one of the nation’s leading food and beverage companies. He also represented clients in substantial litigation arising out of the financial crisis.\nBrandon has served on the firm’s hiring committee and is active in the firm’s efforts to recruit new attorneys. He is a member of the Georgia and Illinois bars, as well as the Atlanta Bar Association.\nPublications\n\nCFPB Proposes Rule Prohibiting Class Action Waivers And Requiring Reporting Of Arbitration Information, Client Alert, May 11, 2016.\nProfiting Under the Veil of Compensation: Wills v. Foster and the Application of the Collateral Source Rule to Medicare and Medicaid, 58 DePaul L. Rev. 789 (2009)\n\n  Partner University of Colorado at Boulder University of Colorado School of Law DePaul University DePaul University College of Law U.S. Court of Appeals for the Third Circuit U.S. Court of Appeals for the Sixth Circuit U.S. Court of Appeals for the Eighth Circuit U.S. Court of Appeals for the Ninth Circuit U.S. Court of Appeals for the Eleventh Circuit U.S. District Court for the Northern District of Illinois U.S. District Court for the Northern District of Georgia Georgia Illinois Representing SCANA Corporation in various litigation matters arising out of the abandonment of SCANA’s new nuclear power development at the V.C. Summer nuclear station in South Carolina, including the defense of ratepayer class actions, securities class action litigation, shareholder derivative lawsuits, and a regulatory proceeding in which SCANA achieved approval for a proposed $14.6 billion merger with Dominion Energy. Representing Equifax, Inc. in securities class action litigation and related government investigations arising out of the data breach announced in September 2017. Representing Quorum Health Corporation, an owner and operator of acute care hospitals, and its former officers in defense of securities class action and derivative litigation relating to Quorum’s spin-off from its former parent company. Representing U.S. Xpress Enterprises, Inc., a large truckload carrier, and its directors and officers in securities class action litigation relating to the company’s 2018 initial public offering. Representing Tivity Health, Inc., a provider of health and fitness improvement programs, and its directors and officers in securities class action and derivative litigation. Representing Acadia Healthcare Company, Inc., an owner and operater of behavioral healthcare facilities, and its directors and officers in securities class action litigation. Representing Aeterna Zentaris, Inc., a biopharmaceutical company, and certain of its former officers in securities class action litigation arising out of the FDA’s rejection of the company’s New Drug Application. Representing a leading company in the payment processing industry in connection with class action litigation brought on behalf of merchants. Represented an international airline in defense of a commercial dispute for alleged breach of contract. Represented one of the world’s leading food and beverage companies in defense of various consumer class action litigation.","searchable_name":"Brandon R. Keel","is_active":true,"featured":null,"publish_date":null,"expiration_date":null,"blog_featured":null,"published_by":202,"capability_group_featured":null,"home_page_featured":null},{"id":445387,"version":1,"owner_type":"Person","owner_id":2473,"payload":{"bio":"\u003cp\u003eChris Kenny is a partner in our Healthcare practice and specializes in providing strategic payment and compliance advice to hospitals, health systems, academic medical centers, and other organizations participating in Medicare, Medicaid and commercial insurance plans.\u0026nbsp; For the past nine years, Chris has been recognized by \u003cem\u003eChambers USA\u003c/em\u003e as a leading healthcare lawyer and in 2020 was named a Top Attorney Under 40 by\u0026nbsp;\u003cem\u003eLaw 360\u003c/em\u003e.[[--readmore--]]\u003c/p\u003e\n\u003cp\u003eWith in-depth knowledge of payment systems and regulations, Chris\u0026nbsp;regularly advises in-house lawyers and C-suite executives on the payment implications of major business decisions including facility construction/acquisition,\u0026nbsp;medical staff relations, the operation\u0026nbsp;and expansion of graduate medical education and allied health training programs,\u0026nbsp;organ acquisition program management, participation in the 340B Drug Pricing Program,\u0026nbsp;and telehealth expansion.\u0026nbsp;\u0026nbsp;\u003c/p\u003e\n\u003cp\u003eApplying his regulatory and reimbursement experience, Chris represents hospitals in Medicare payment litigation\u0026nbsp;and before Congress and the administrative branch, as well as in\u0026nbsp;False Claims Act investigations by the U.S. Department of Justice.\u003c/p\u003e\n\u003cp\u003eHe strives to provide creative, proactive advice in an ever-changing healthcare regulatory environment, and to vigorously defend his clients\u0026rsquo; positions in payment disputes and government investigations.\u003c/p\u003e\n\u003cp\u003eA member of the Healthcare Financial Management Association and the American Health Lawyers Association, Chris regularly speaks and writes on reimbursement and compliance issues. He is the co-editor of the \u003cem\u003eReimbursement Advisor,\u003c/em\u003e the leading national healthcare reimbursement publication, and serves as co-editor of our firm\u0026rsquo;s award-winning \u003cem\u003eHealth Headlines\u003c/em\u003e, a weekly newsletter summarizing healthcare law and policy developments.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eADMITTED TO PRACTICE IN DISTRICT OF COLUMBIA AND MARYLAND; NOT ADMITTED TO PRACTICE IN FLORIDA\u003c/strong\u003e\u003c/p\u003e","slug":"christopher-kenny","email":"ckenny@kslaw.com","phone":null,"matters":["\u003cp\u003eRepresented the Florida Hospital Association and 12 of its members in a precedent-setting challenge to CMS's exclusion of section 1115 waiver days from the Medicare DSH payment adjustment, resulting in a multi-million dollar victory.\u0026nbsp;\u003cem\u003eSee Bethesda Health v. Azar\u003c/em\u003e, 980 F.3d 121 (D.C. Cir. 2020). Mr. Kenny is currently pursuing the same issue on behalf of dozens more hospitals in Florida, Texas, California, Tennessee and elsewhere, with total amounts in controversy worth hundreds of millions of dollars.\u003c/p\u003e","\u003cp\u003eRepresented 34 hospitals in overturning CMS's unlawful policy understating the so-called \"rural floor,\" generating hundreds of millions of dollars in additional wage-related payments for providers in Arizona, Connecticut, Florida, and elsewhere.\u0026nbsp;\u003cem\u003eCitrus HMA v. Azar\u003c/em\u003e, Case No. 20-00707, 2022 WL 1062990 (D.D.C. 2022).\u003c/p\u003e","\u003cp\u003eSuccessfully represented five major health systems in overturning CMS's disallowance of millions of dollars in financial support for the hospitals' nursing and other training programs. The court noted \"the hosptials are right, and it is not even close.\"\u0026nbsp;\u003cem\u003eMercy Health-St. Vincent Medical Center v. Becerra\u003c/em\u003e, Case No. 22-3578 (D.D.C. 2024).\u003c/p\u003e","\u003cp\u003eRegularly provides day-to-day counseling to more than a dozen major health systems in the establishment and operation of large outpatient provider-based facilities and rural health clinics. Issues involved include the structuring of complex management agreements, joint ventures, 340B considerations, service line collaborations, and hospital-physician relationships.\u003c/p\u003e","\u003cp\u003eSuccessfully represented a Medicaid managed care organization in multiple False Claims Act investigations by local U.S. Attorneys' Offices resulting in declinations.\u003c/p\u003e","\u003cp\u003eRecovered millions of dollars in additional cost reimbursement for an organ procurement organization's clinical laboratory activities.\u003c/p\u003e"],"taggings":{"tags":[],"meta_tags":[{"id":116}]},"expertise":[{"id":103,"guid":"103.capabilities","index":0,"source":"capabilities"},{"id":21,"guid":"21.capabilities","index":1,"source":"capabilities"},{"id":23,"guid":"23.capabilities","index":2,"source":"capabilities"},{"id":81,"guid":"81.capabilities","index":3,"source":"capabilities"},{"id":12,"guid":"12.capabilities","index":4,"source":"capabilities"},{"id":24,"guid":"24.capabilities","index":5,"source":"capabilities"},{"id":826,"guid":"826.smart_tags","index":6,"source":"smartTags"},{"id":114,"guid":"114.capabilities","index":7,"source":"capabilities"},{"id":122,"guid":"122.capabilities","index":8,"source":"capabilities"},{"id":1185,"guid":"1185.smart_tags","index":9,"source":"smartTags"},{"id":1202,"guid":"1202.smart_tags","index":10,"source":"smartTags"}],"is_active":true,"last_name":"Kenny","nick_name":"Chris","clerkships":[],"first_name":"Christopher","title_rank":9999,"updated_by":35,"law_schools":[],"middle_name":"P.","name_suffix":"","recognitions":[{"title":"2020 Top Attorneys Under 40 - Healthcare","detail":"Law360"},{"title":"Ranked in Chambers USA for Healthcare 2017-2021","detail":"Chambers USA"},{"title":"Named a Rising Star in Healthcare","detail":"SUPER LAWYERS, 2018"},{"title":"Named a Rising Star in Healthcare","detail":"Super Lawyers, 2017"}],"linked_in_url":null,"seodescription":null,"primary_title_id":15,"translated_fields":{"en":{"bio":"\u003cp\u003eChris Kenny is a partner in our Healthcare practice and specializes in providing strategic payment and compliance advice to hospitals, health systems, academic medical centers, and other organizations participating in Medicare, Medicaid and commercial insurance plans.\u0026nbsp; For the past nine years, Chris has been recognized by \u003cem\u003eChambers USA\u003c/em\u003e as a leading healthcare lawyer and in 2020 was named a Top Attorney Under 40 by\u0026nbsp;\u003cem\u003eLaw 360\u003c/em\u003e.[[--readmore--]]\u003c/p\u003e\n\u003cp\u003eWith in-depth knowledge of payment systems and regulations, Chris\u0026nbsp;regularly advises in-house lawyers and C-suite executives on the payment implications of major business decisions including facility construction/acquisition,\u0026nbsp;medical staff relations, the operation\u0026nbsp;and expansion of graduate medical education and allied health training programs,\u0026nbsp;organ acquisition program management, participation in the 340B Drug Pricing Program,\u0026nbsp;and telehealth expansion.\u0026nbsp;\u0026nbsp;\u003c/p\u003e\n\u003cp\u003eApplying his regulatory and reimbursement experience, Chris represents hospitals in Medicare payment litigation\u0026nbsp;and before Congress and the administrative branch, as well as in\u0026nbsp;False Claims Act investigations by the U.S. Department of Justice.\u003c/p\u003e\n\u003cp\u003eHe strives to provide creative, proactive advice in an ever-changing healthcare regulatory environment, and to vigorously defend his clients\u0026rsquo; positions in payment disputes and government investigations.\u003c/p\u003e\n\u003cp\u003eA member of the Healthcare Financial Management Association and the American Health Lawyers Association, Chris regularly speaks and writes on reimbursement and compliance issues. He is the co-editor of the \u003cem\u003eReimbursement Advisor,\u003c/em\u003e the leading national healthcare reimbursement publication, and serves as co-editor of our firm\u0026rsquo;s award-winning \u003cem\u003eHealth Headlines\u003c/em\u003e, a weekly newsletter summarizing healthcare law and policy developments.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eADMITTED TO PRACTICE IN DISTRICT OF COLUMBIA AND MARYLAND; NOT ADMITTED TO PRACTICE IN FLORIDA\u003c/strong\u003e\u003c/p\u003e","matters":["\u003cp\u003eRepresented the Florida Hospital Association and 12 of its members in a precedent-setting challenge to CMS's exclusion of section 1115 waiver days from the Medicare DSH payment adjustment, resulting in a multi-million dollar victory.\u0026nbsp;\u003cem\u003eSee Bethesda Health v. Azar\u003c/em\u003e, 980 F.3d 121 (D.C. Cir. 2020). Mr. Kenny is currently pursuing the same issue on behalf of dozens more hospitals in Florida, Texas, California, Tennessee and elsewhere, with total amounts in controversy worth hundreds of millions of dollars.\u003c/p\u003e","\u003cp\u003eRepresented 34 hospitals in overturning CMS's unlawful policy understating the so-called \"rural floor,\" generating hundreds of millions of dollars in additional wage-related payments for providers in Arizona, Connecticut, Florida, and elsewhere.\u0026nbsp;\u003cem\u003eCitrus HMA v. Azar\u003c/em\u003e, Case No. 20-00707, 2022 WL 1062990 (D.D.C. 2022).\u003c/p\u003e","\u003cp\u003eSuccessfully represented five major health systems in overturning CMS's disallowance of millions of dollars in financial support for the hospitals' nursing and other training programs. The court noted \"the hosptials are right, and it is not even close.\"\u0026nbsp;\u003cem\u003eMercy Health-St. Vincent Medical Center v. Becerra\u003c/em\u003e, Case No. 22-3578 (D.D.C. 2024).\u003c/p\u003e","\u003cp\u003eRegularly provides day-to-day counseling to more than a dozen major health systems in the establishment and operation of large outpatient provider-based facilities and rural health clinics. Issues involved include the structuring of complex management agreements, joint ventures, 340B considerations, service line collaborations, and hospital-physician relationships.\u003c/p\u003e","\u003cp\u003eSuccessfully represented a Medicaid managed care organization in multiple False Claims Act investigations by local U.S. Attorneys' Offices resulting in declinations.\u003c/p\u003e","\u003cp\u003eRecovered millions of dollars in additional cost reimbursement for an organ procurement organization's clinical laboratory activities.\u003c/p\u003e"],"recognitions":[{"title":"2020 Top Attorneys Under 40 - Healthcare","detail":"Law360"},{"title":"Ranked in Chambers USA for Healthcare 2017-2021","detail":"Chambers USA"},{"title":"Named a Rising Star in Healthcare","detail":"SUPER LAWYERS, 2018"},{"title":"Named a Rising Star in Healthcare","detail":"Super Lawyers, 2017"}]},"locales":["en"]},"secondary_title_id":null,"upload_assignments":{"headshot":[{"id":10000}]},"capability_group_id":2},"created_at":"2026-01-30T19:46:10.000Z","updated_at":"2026-01-30T19:46:10.000Z","searchable_text":"Kenny{{ FIELD }}{:title=\u0026gt;\"2020 Top Attorneys Under 40 - Healthcare\", :detail=\u0026gt;\"Law360\"}{{ FIELD }}{:title=\u0026gt;\"Ranked in Chambers USA for Healthcare 2017-2021\", :detail=\u0026gt;\"Chambers USA\"}{{ FIELD }}{:title=\u0026gt;\"Named a Rising Star in Healthcare\", :detail=\u0026gt;\"SUPER LAWYERS, 2018\"}{{ FIELD }}{:title=\u0026gt;\"Named a Rising Star in Healthcare\", :detail=\u0026gt;\"Super Lawyers, 2017\"}{{ FIELD }}Represented the Florida Hospital Association and 12 of its members in a precedent-setting challenge to CMS's exclusion of section 1115 waiver days from the Medicare DSH payment adjustment, resulting in a multi-million dollar victory. See Bethesda Health v. Azar, 980 F.3d 121 (D.C. Cir. 2020). Mr. Kenny is currently pursuing the same issue on behalf of dozens more hospitals in Florida, Texas, California, Tennessee and elsewhere, with total amounts in controversy worth hundreds of millions of dollars.{{ FIELD }}Represented 34 hospitals in overturning CMS's unlawful policy understating the so-called \"rural floor,\" generating hundreds of millions of dollars in additional wage-related payments for providers in Arizona, Connecticut, Florida, and elsewhere. Citrus HMA v. Azar, Case No. 20-00707, 2022 WL 1062990 (D.D.C. 2022).{{ FIELD }}Successfully represented five major health systems in overturning CMS's disallowance of millions of dollars in financial support for the hospitals' nursing and other training programs. The court noted \"the hosptials are right, and it is not even close.\" Mercy Health-St. Vincent Medical Center v. Becerra, Case No. 22-3578 (D.D.C. 2024).{{ FIELD }}Regularly provides day-to-day counseling to more than a dozen major health systems in the establishment and operation of large outpatient provider-based facilities and rural health clinics. Issues involved include the structuring of complex management agreements, joint ventures, 340B considerations, service line collaborations, and hospital-physician relationships.{{ FIELD }}Successfully represented a Medicaid managed care organization in multiple False Claims Act investigations by local U.S. Attorneys' Offices resulting in declinations.{{ FIELD }}Recovered millions of dollars in additional cost reimbursement for an organ procurement organization's clinical laboratory activities.{{ FIELD }}Chris Kenny is a partner in our Healthcare practice and specializes in providing strategic payment and compliance advice to hospitals, health systems, academic medical centers, and other organizations participating in Medicare, Medicaid and commercial insurance plans.  For the past nine years, Chris has been recognized by Chambers USA as a leading healthcare lawyer and in 2020 was named a Top Attorney Under 40 by Law 360.\nWith in-depth knowledge of payment systems and regulations, Chris regularly advises in-house lawyers and C-suite executives on the payment implications of major business decisions including facility construction/acquisition, medical staff relations, the operation and expansion of graduate medical education and allied health training programs, organ acquisition program management, participation in the 340B Drug Pricing Program, and telehealth expansion.  \nApplying his regulatory and reimbursement experience, Chris represents hospitals in Medicare payment litigation and before Congress and the administrative branch, as well as in False Claims Act investigations by the U.S. Department of Justice.\nHe strives to provide creative, proactive advice in an ever-changing healthcare regulatory environment, and to vigorously defend his clients’ positions in payment disputes and government investigations.\nA member of the Healthcare Financial Management Association and the American Health Lawyers Association, Chris regularly speaks and writes on reimbursement and compliance issues. He is the co-editor of the Reimbursement Advisor, the leading national healthcare reimbursement publication, and serves as co-editor of our firm’s award-winning Health Headlines, a weekly newsletter summarizing healthcare law and policy developments.\nADMITTED TO PRACTICE IN DISTRICT OF COLUMBIA AND MARYLAND; NOT ADMITTED TO PRACTICE IN FLORIDA Christopher P Kenny Partner 2020 Top Attorneys Under 40 - Healthcare Law360 Ranked in Chambers USA for Healthcare 2017-2021 Chambers USA Named a Rising Star in Healthcare SUPER LAWYERS, 2018 Named a Rising Star in Healthcare Super Lawyers, 2017 Northwestern University Northwestern Pritzker School of Law George Washington University George Washington University Law School U.S. Court of Appeals for the D.C. Circuit U.S. District Court for the District of Columbia District of Columbia Maryland American Health Lawyers Association Healthcare Financial Management Association Represented the Florida Hospital Association and 12 of its members in a precedent-setting challenge to CMS's exclusion of section 1115 waiver days from the Medicare DSH payment adjustment, resulting in a multi-million dollar victory. See Bethesda Health v. Azar, 980 F.3d 121 (D.C. Cir. 2020). Mr. Kenny is currently pursuing the same issue on behalf of dozens more hospitals in Florida, Texas, California, Tennessee and elsewhere, with total amounts in controversy worth hundreds of millions of dollars. Represented 34 hospitals in overturning CMS's unlawful policy understating the so-called \"rural floor,\" generating hundreds of millions of dollars in additional wage-related payments for providers in Arizona, Connecticut, Florida, and elsewhere. Citrus HMA v. Azar, Case No. 20-00707, 2022 WL 1062990 (D.D.C. 2022). Successfully represented five major health systems in overturning CMS's disallowance of millions of dollars in financial support for the hospitals' nursing and other training programs. The court noted \"the hosptials are right, and it is not even close.\" Mercy Health-St. Vincent Medical Center v. Becerra, Case No. 22-3578 (D.D.C. 2024). Regularly provides day-to-day counseling to more than a dozen major health systems in the establishment and operation of large outpatient provider-based facilities and rural health clinics. Issues involved include the structuring of complex management agreements, joint ventures, 340B considerations, service line collaborations, and hospital-physician relationships. Successfully represented a Medicaid managed care organization in multiple False Claims Act investigations by local U.S. Attorneys' Offices resulting in declinations. Recovered millions of dollars in additional cost reimbursement for an organ procurement organization's clinical laboratory activities.","searchable_name":"Christopher P. Kenny (Chris)","is_active":true,"featured":null,"publish_date":null,"expiration_date":null,"blog_featured":null,"published_by":35,"capability_group_featured":null,"home_page_featured":null},{"id":440298,"version":1,"owner_type":"Person","owner_id":2100,"payload":{"bio":"\u003cp\u003eAmanda Klingler is a partner in the firm\u0026rsquo;s Washington, D.C. and Chicago offices with extensive experience advising life science clients.\u0026nbsp; As a partner in the firm's FDA and Life Sciences practice, Amanda advises pharmaceutical, medical device and biotech companies and pharmacies, on a wide range of regulatory matters, enforcement actions, civil litigation, investigations, product liability litigation, and compliance counseling.\u0026nbsp;[[--readmore--]]\u003c/p\u003e\n\u003cp\u003eAmanda counsels clients on pre- and post-marketing regulatory activities and strategies, including obtaining FDA approval and clearance for medical products.\u0026nbsp; Amanda also regularly advises clients on product labeling, adverse event reporting, product safety issues, recalls/field corrections, import detention, and advertising and promotion issues.\u0026nbsp; She counsels clients on quality system and manufacturing practices for drugs and medical devices and factory inspections, including conducting mock inspections and working closely with and providing advice to clients during the inspection, and provide guidance in responding to FDA investigational observations (FDA-483 forms), and warning letters.\u0026nbsp;\u0026nbsp;Amanda, as a co-leader of the firm\u0026rsquo;s AI/ML Tactical Operations team, also frequently advises clients on the use of AI/ML during the life cycle of drugs and medical devices, including digital health products.\u0026nbsp;\u003c/p\u003e\n\u003cp\u003eAmanda advises clients during internal and government investigations.\u0026nbsp; She also assists in the negotiation and management of several consent decrees of injunction for pharmaceutical, medical device, food companies and compounding pharmacies.\u003c/p\u003e\n\u003cp\u003eAmanda works closely with the firm's product liability team and is experienced in handling FDA issues in product liability litigation, including the development of supporting evidence, writing briefs, and preparing expert witnesses to testify.\u003c/p\u003e\n\u003cp\u003eAmanda also has significant experience and expertise in FDA's regulation of tobacco products.\u003c/p\u003e","slug":"amanda-klingler","email":"aklingler@kslaw.com","phone":null,"matters":["\u003cp\u003e\u003cem\u003ePhillips Morris USA v. FDA,\u0026nbsp;\u003c/em\u003e202 F.Supp. 3d (D.D.C. 2016). Represented one of the plaintiffs in a successful legal challenge to an FDA guidance governing the Substantial Equivalence Review process for tobacco products.\u003c/p\u003e","\u003cp\u003eMember of a King \u0026amp; Spalding team serving as national coordinating counsel and trial counsel in\u0026nbsp;\u003cstrong data-redactor-tag=\"strong\"\u003eproduct liability litigation\u003c/strong\u003einvolving GlaxoSmithKline\u0026rsquo;s antidepressant Paxil\u0026reg;, including in the Philadelphia Court of Common Pleas Mass Tort Program. Experience includes preparing fact and expert witnesses on FDA issues and briefing motions\u0026nbsp;\u003cem data-redactor-tag=\"em\"\u003ein limine\u003c/em\u003e\u0026nbsp;and\u0026nbsp;\u003cem data-redactor-tag=\"em\"\u003eDaubert\u003c/em\u003echallenges.\u003c/p\u003e","\u003cp\u003eMember of a King \u0026amp; Spalding team representing the\u0026nbsp;\u003cstrong\u003emanufacturer of FDA-cleared surgical gowns\u0026nbsp;\u003c/strong\u003ein nationwide litigation concerning the design, labeling, advertising and manufacture of the devices, including: a federal class action trial, the verdict from which is on appeal to the Ninth Circuit; a\u0026nbsp;\u003cem\u003equi tam\u0026nbsp;\u003c/em\u003esuit brought under the Federal False Claims Act in which the court granted defendants' motion to dismiss; and a federal Lanham Act lawsuit concerning allegations of false marketing. Experience includes working extensively with the Company's regulatory expert witness on the FDA-related issues in the litigation, leading the development of the Company's expert report and preparing the witness for his trial testimony.\u003c/p\u003e","\u003cp\u003eAssisted\u0026nbsp;\u003cstrong data-redactor-tag=\"strong\"\u003ecompanies in preparing for FDA inspections,\u003c/strong\u003e\u0026nbsp;developing responses to FDA investigational observations (FDA-483 forms), and warning letters.\u003c/p\u003e","\u003cp\u003eAssisted\u0026nbsp;\u003cstrong data-redactor-tag=\"strong\"\u003epharmaceutical and medical device companies\u003c/strong\u003e\u0026nbsp;under investigation by FDA and the U.S. Department of Justice Office for alleged violations of the FDCA.\u003c/p\u003e","\u003cp\u003eConducted\u0026nbsp;\u003cstrong\u003einternal investigations of pharmaceutical medical device manufacturers\u003c/strong\u003e\u0026nbsp;into potential quality systems and advertising and promotion violations to develop a risk profile and recommendation for reducing potential liability and risk exposure.\u003c/p\u003e","\u003cp\u003eConducted\u0026nbsp;\u003cstrong data-redactor-tag=\"strong\"\u003eFDA regulatory due diligence reviews\u003c/strong\u003e\u0026nbsp;of target medical device, pharmaceutical manufacturers, and compounding pharmacies.\u003c/p\u003e","\u003cp\u003eCounseled companies on\u0026nbsp;\u003cstrong data-redactor-tag=\"strong\"\u003eradiation-emitting product requirements\u003c/strong\u003e\u0026nbsp;under the FDCA.\u003c/p\u003e","\u003cp\u003eCounseled companies on\u0026nbsp;\u003cstrong data-redactor-tag=\"strong\"\u003elabeling and promotion requirements\u003c/strong\u003e\u0026nbsp;for FDA-regulated products.\u003c/p\u003e","\u003cp\u003e\u003cem data-redactor-tag=\"em\"\u003eUnited States v. Franck\u0026rsquo;s Lab\u003c/em\u003e, 2011 WL 4031102 (M.D. Fla. Sept. 12, 2011). Lead associate for\u0026nbsp;\u003cstrong data-redactor-tag=\"strong\"\u003eFranck\u0026rsquo;s Lab\u003c/strong\u003e\u0026nbsp;in successful defense of FDA enforcement action contending that traditional, state-licensed pharmacy compounding of veterinary medications violates FDA\u0026rsquo;s statute. Also served as the lead associate for Franck\u0026rsquo;s Lab in other FDA regulatory and state board of pharmacy matters.\u003c/p\u003e","\u003cp\u003e\u003cem data-redactor-tag=\"em\"\u003eHill Dermaceuticals, Inc. v.\u003c/em\u003e\u0026nbsp;FDA, No. 1:11-cv-01950 (D.D.C.). Lead associate representing\u0026nbsp;\u003cstrong data-redactor-tag=\"strong\"\u003einnovator drug manufacturer\u003c/strong\u003e\u0026nbsp;in litigation seeking to require FDA to withdraw its approval of purported generic formulations of manufacturer\u0026rsquo;s brand name products.\u003c/p\u003e"],"taggings":{"tags":[],"meta_tags":[{"id":174}]},"expertise":[{"id":81,"guid":"81.capabilities","index":0,"source":"capabilities"},{"id":103,"guid":"103.capabilities","index":1,"source":"capabilities"},{"id":21,"guid":"21.capabilities","index":2,"source":"capabilities"},{"id":17,"guid":"17.capabilities","index":3,"source":"capabilities"},{"id":114,"guid":"114.capabilities","index":4,"source":"capabilities"},{"id":122,"guid":"122.capabilities","index":5,"source":"capabilities"},{"id":1199,"guid":"1199.smart_tags","index":6,"source":"smartTags"},{"id":1202,"guid":"1202.smart_tags","index":7,"source":"smartTags"},{"id":1223,"guid":"1223.smart_tags","index":8,"source":"smartTags"},{"id":128,"guid":"128.capabilities","index":9,"source":"capabilities"},{"id":133,"guid":"133.capabilities","index":10,"source":"capabilities"},{"id":1206,"guid":"1206.smart_tags","index":11,"source":"smartTags"}],"is_active":true,"last_name":"Klingler","nick_name":"Amanda","clerkships":[],"first_name":"Amanda","title_rank":9999,"updated_by":202,"law_schools":[],"middle_name":"J.","name_suffix":"","recognitions":null,"linked_in_url":null,"seodescription":null,"primary_title_id":15,"translated_fields":{"en":{"bio":"\u003cp\u003eAmanda Klingler is a partner in the firm\u0026rsquo;s Washington, D.C. and Chicago offices with extensive experience advising life science clients.\u0026nbsp; As a partner in the firm's FDA and Life Sciences practice, Amanda advises pharmaceutical, medical device and biotech companies and pharmacies, on a wide range of regulatory matters, enforcement actions, civil litigation, investigations, product liability litigation, and compliance counseling.\u0026nbsp;[[--readmore--]]\u003c/p\u003e\n\u003cp\u003eAmanda counsels clients on pre- and post-marketing regulatory activities and strategies, including obtaining FDA approval and clearance for medical products.\u0026nbsp; Amanda also regularly advises clients on product labeling, adverse event reporting, product safety issues, recalls/field corrections, import detention, and advertising and promotion issues.\u0026nbsp; She counsels clients on quality system and manufacturing practices for drugs and medical devices and factory inspections, including conducting mock inspections and working closely with and providing advice to clients during the inspection, and provide guidance in responding to FDA investigational observations (FDA-483 forms), and warning letters.\u0026nbsp;\u0026nbsp;Amanda, as a co-leader of the firm\u0026rsquo;s AI/ML Tactical Operations team, also frequently advises clients on the use of AI/ML during the life cycle of drugs and medical devices, including digital health products.\u0026nbsp;\u003c/p\u003e\n\u003cp\u003eAmanda advises clients during internal and government investigations.\u0026nbsp; She also assists in the negotiation and management of several consent decrees of injunction for pharmaceutical, medical device, food companies and compounding pharmacies.\u003c/p\u003e\n\u003cp\u003eAmanda works closely with the firm's product liability team and is experienced in handling FDA issues in product liability litigation, including the development of supporting evidence, writing briefs, and preparing expert witnesses to testify.\u003c/p\u003e\n\u003cp\u003eAmanda also has significant experience and expertise in FDA's regulation of tobacco products.\u003c/p\u003e","matters":["\u003cp\u003e\u003cem\u003ePhillips Morris USA v. FDA,\u0026nbsp;\u003c/em\u003e202 F.Supp. 3d (D.D.C. 2016). Represented one of the plaintiffs in a successful legal challenge to an FDA guidance governing the Substantial Equivalence Review process for tobacco products.\u003c/p\u003e","\u003cp\u003eMember of a King \u0026amp; Spalding team serving as national coordinating counsel and trial counsel in\u0026nbsp;\u003cstrong data-redactor-tag=\"strong\"\u003eproduct liability litigation\u003c/strong\u003einvolving GlaxoSmithKline\u0026rsquo;s antidepressant Paxil\u0026reg;, including in the Philadelphia Court of Common Pleas Mass Tort Program. Experience includes preparing fact and expert witnesses on FDA issues and briefing motions\u0026nbsp;\u003cem data-redactor-tag=\"em\"\u003ein limine\u003c/em\u003e\u0026nbsp;and\u0026nbsp;\u003cem data-redactor-tag=\"em\"\u003eDaubert\u003c/em\u003echallenges.\u003c/p\u003e","\u003cp\u003eMember of a King \u0026amp; Spalding team representing the\u0026nbsp;\u003cstrong\u003emanufacturer of FDA-cleared surgical gowns\u0026nbsp;\u003c/strong\u003ein nationwide litigation concerning the design, labeling, advertising and manufacture of the devices, including: a federal class action trial, the verdict from which is on appeal to the Ninth Circuit; a\u0026nbsp;\u003cem\u003equi tam\u0026nbsp;\u003c/em\u003esuit brought under the Federal False Claims Act in which the court granted defendants' motion to dismiss; and a federal Lanham Act lawsuit concerning allegations of false marketing. Experience includes working extensively with the Company's regulatory expert witness on the FDA-related issues in the litigation, leading the development of the Company's expert report and preparing the witness for his trial testimony.\u003c/p\u003e","\u003cp\u003eAssisted\u0026nbsp;\u003cstrong data-redactor-tag=\"strong\"\u003ecompanies in preparing for FDA inspections,\u003c/strong\u003e\u0026nbsp;developing responses to FDA investigational observations (FDA-483 forms), and warning letters.\u003c/p\u003e","\u003cp\u003eAssisted\u0026nbsp;\u003cstrong data-redactor-tag=\"strong\"\u003epharmaceutical and medical device companies\u003c/strong\u003e\u0026nbsp;under investigation by FDA and the U.S. Department of Justice Office for alleged violations of the FDCA.\u003c/p\u003e","\u003cp\u003eConducted\u0026nbsp;\u003cstrong\u003einternal investigations of pharmaceutical medical device manufacturers\u003c/strong\u003e\u0026nbsp;into potential quality systems and advertising and promotion violations to develop a risk profile and recommendation for reducing potential liability and risk exposure.\u003c/p\u003e","\u003cp\u003eConducted\u0026nbsp;\u003cstrong data-redactor-tag=\"strong\"\u003eFDA regulatory due diligence reviews\u003c/strong\u003e\u0026nbsp;of target medical device, pharmaceutical manufacturers, and compounding pharmacies.\u003c/p\u003e","\u003cp\u003eCounseled companies on\u0026nbsp;\u003cstrong data-redactor-tag=\"strong\"\u003eradiation-emitting product requirements\u003c/strong\u003e\u0026nbsp;under the FDCA.\u003c/p\u003e","\u003cp\u003eCounseled companies on\u0026nbsp;\u003cstrong data-redactor-tag=\"strong\"\u003elabeling and promotion requirements\u003c/strong\u003e\u0026nbsp;for FDA-regulated products.\u003c/p\u003e","\u003cp\u003e\u003cem data-redactor-tag=\"em\"\u003eUnited States v. Franck\u0026rsquo;s Lab\u003c/em\u003e, 2011 WL 4031102 (M.D. Fla. Sept. 12, 2011). Lead associate for\u0026nbsp;\u003cstrong data-redactor-tag=\"strong\"\u003eFranck\u0026rsquo;s Lab\u003c/strong\u003e\u0026nbsp;in successful defense of FDA enforcement action contending that traditional, state-licensed pharmacy compounding of veterinary medications violates FDA\u0026rsquo;s statute. Also served as the lead associate for Franck\u0026rsquo;s Lab in other FDA regulatory and state board of pharmacy matters.\u003c/p\u003e","\u003cp\u003e\u003cem data-redactor-tag=\"em\"\u003eHill Dermaceuticals, Inc. v.\u003c/em\u003e\u0026nbsp;FDA, No. 1:11-cv-01950 (D.D.C.). Lead associate representing\u0026nbsp;\u003cstrong data-redactor-tag=\"strong\"\u003einnovator drug manufacturer\u003c/strong\u003e\u0026nbsp;in litigation seeking to require FDA to withdraw its approval of purported generic formulations of manufacturer\u0026rsquo;s brand name products.\u003c/p\u003e"]},"locales":["en"]},"secondary_title_id":null,"upload_assignments":{"headshot":[{"id":4350}]},"capability_group_id":2},"created_at":"2025-10-08T19:11:18.000Z","updated_at":"2025-10-08T19:11:18.000Z","searchable_text":"Klingler{{ FIELD }}Phillips Morris USA v. FDA, 202 F.Supp. 3d (D.D.C. 2016). Represented one of the plaintiffs in a successful legal challenge to an FDA guidance governing the Substantial Equivalence Review process for tobacco products.{{ FIELD }}Member of a King \u0026amp; Spalding team serving as national coordinating counsel and trial counsel in product liability litigationinvolving GlaxoSmithKline’s antidepressant Paxil®, including in the Philadelphia Court of Common Pleas Mass Tort Program. Experience includes preparing fact and expert witnesses on FDA issues and briefing motions in limine and Daubertchallenges.{{ FIELD }}Member of a King \u0026amp; Spalding team representing the manufacturer of FDA-cleared surgical gowns in nationwide litigation concerning the design, labeling, advertising and manufacture of the devices, including: a federal class action trial, the verdict from which is on appeal to the Ninth Circuit; a qui tam suit brought under the Federal False Claims Act in which the court granted defendants' motion to dismiss; and a federal Lanham Act lawsuit concerning allegations of false marketing. Experience includes working extensively with the Company's regulatory expert witness on the FDA-related issues in the litigation, leading the development of the Company's expert report and preparing the witness for his trial testimony.{{ FIELD }}Assisted companies in preparing for FDA inspections, developing responses to FDA investigational observations (FDA-483 forms), and warning letters.{{ FIELD }}Assisted pharmaceutical and medical device companies under investigation by FDA and the U.S. Department of Justice Office for alleged violations of the FDCA.{{ FIELD }}Conducted internal investigations of pharmaceutical medical device manufacturers into potential quality systems and advertising and promotion violations to develop a risk profile and recommendation for reducing potential liability and risk exposure.{{ FIELD }}Conducted FDA regulatory due diligence reviews of target medical device, pharmaceutical manufacturers, and compounding pharmacies.{{ FIELD }}Counseled companies on radiation-emitting product requirements under the FDCA.{{ FIELD }}Counseled companies on labeling and promotion requirements for FDA-regulated products.{{ FIELD }}United States v. Franck’s Lab, 2011 WL 4031102 (M.D. Fla. Sept. 12, 2011). Lead associate for Franck’s Lab in successful defense of FDA enforcement action contending that traditional, state-licensed pharmacy compounding of veterinary medications violates FDA’s statute. Also served as the lead associate for Franck’s Lab in other FDA regulatory and state board of pharmacy matters.{{ FIELD }}Hill Dermaceuticals, Inc. v. FDA, No. 1:11-cv-01950 (D.D.C.). Lead associate representing innovator drug manufacturer in litigation seeking to require FDA to withdraw its approval of purported generic formulations of manufacturer’s brand name products.{{ FIELD }}Amanda Klingler is a partner in the firm’s Washington, D.C. and Chicago offices with extensive experience advising life science clients.  As a partner in the firm's FDA and Life Sciences practice, Amanda advises pharmaceutical, medical device and biotech companies and pharmacies, on a wide range of regulatory matters, enforcement actions, civil litigation, investigations, product liability litigation, and compliance counseling. \nAmanda counsels clients on pre- and post-marketing regulatory activities and strategies, including obtaining FDA approval and clearance for medical products.  Amanda also regularly advises clients on product labeling, adverse event reporting, product safety issues, recalls/field corrections, import detention, and advertising and promotion issues.  She counsels clients on quality system and manufacturing practices for drugs and medical devices and factory inspections, including conducting mock inspections and working closely with and providing advice to clients during the inspection, and provide guidance in responding to FDA investigational observations (FDA-483 forms), and warning letters.  Amanda, as a co-leader of the firm’s AI/ML Tactical Operations team, also frequently advises clients on the use of AI/ML during the life cycle of drugs and medical devices, including digital health products. \nAmanda advises clients during internal and government investigations.  She also assists in the negotiation and management of several consent decrees of injunction for pharmaceutical, medical device, food companies and compounding pharmacies.\nAmanda works closely with the firm's product liability team and is experienced in handling FDA issues in product liability litigation, including the development of supporting evidence, writing briefs, and preparing expert witnesses to testify.\nAmanda also has significant experience and expertise in FDA's regulation of tobacco products. Amanda J Klingler Partner University of Richmond University of Richmond School of Law Saint Louis University Saint Louis University School of Law Loyola University Chicago Loyola University Chicago School of Law District of Columbia Illinois Phillips Morris USA v. FDA, 202 F.Supp. 3d (D.D.C. 2016). Represented one of the plaintiffs in a successful legal challenge to an FDA guidance governing the Substantial Equivalence Review process for tobacco products. Member of a King \u0026amp; Spalding team serving as national coordinating counsel and trial counsel in product liability litigationinvolving GlaxoSmithKline’s antidepressant Paxil®, including in the Philadelphia Court of Common Pleas Mass Tort Program. Experience includes preparing fact and expert witnesses on FDA issues and briefing motions in limine and Daubertchallenges. Member of a King \u0026amp; Spalding team representing the manufacturer of FDA-cleared surgical gowns in nationwide litigation concerning the design, labeling, advertising and manufacture of the devices, including: a federal class action trial, the verdict from which is on appeal to the Ninth Circuit; a qui tam suit brought under the Federal False Claims Act in which the court granted defendants' motion to dismiss; and a federal Lanham Act lawsuit concerning allegations of false marketing. Experience includes working extensively with the Company's regulatory expert witness on the FDA-related issues in the litigation, leading the development of the Company's expert report and preparing the witness for his trial testimony. Assisted companies in preparing for FDA inspections, developing responses to FDA investigational observations (FDA-483 forms), and warning letters. Assisted pharmaceutical and medical device companies under investigation by FDA and the U.S. Department of Justice Office for alleged violations of the FDCA. Conducted internal investigations of pharmaceutical medical device manufacturers into potential quality systems and advertising and promotion violations to develop a risk profile and recommendation for reducing potential liability and risk exposure. Conducted FDA regulatory due diligence reviews of target medical device, pharmaceutical manufacturers, and compounding pharmacies. Counseled companies on radiation-emitting product requirements under the FDCA. Counseled companies on labeling and promotion requirements for FDA-regulated products. United States v. Franck’s Lab, 2011 WL 4031102 (M.D. Fla. Sept. 12, 2011). Lead associate for Franck’s Lab in successful defense of FDA enforcement action contending that traditional, state-licensed pharmacy compounding of veterinary medications violates FDA’s statute. Also served as the lead associate for Franck’s Lab in other FDA regulatory and state board of pharmacy matters. Hill Dermaceuticals, Inc. v. FDA, No. 1:11-cv-01950 (D.D.C.). Lead associate representing innovator drug manufacturer in litigation seeking to require FDA to withdraw its approval of purported generic formulations of manufacturer’s brand name products.","searchable_name":"Amanda J. Klingler","is_active":true,"featured":null,"publish_date":null,"expiration_date":null,"blog_featured":null,"published_by":202,"capability_group_featured":null,"home_page_featured":null},{"id":444653,"version":1,"owner_type":"Person","owner_id":5142,"payload":{"bio":"\u003cp\u003eRyan Kearney is a seasoned litigator and trial lawyer with extensive experience in environmental and regulatory compliance, climate change and adaptation, product liability,\u0026nbsp;personal injury and commercial litigation, including mass tort and class action defense in the oil \u0026amp; gas, tobacco, consumer product, medical device, construction, private equity, real estate and transportation industries.[[--readmore--]]\u003c/p\u003e\n\u003cp\u003eRyan is a dedicated advocate for his clients, investing in creative strategies with a results-driven approach that has achieved nine complete defense verdicts for his trial teams in the last seven\u0026nbsp;years, in addition to dozens of favorable resolutions and outright dismissals pre-trial.\u0026nbsp; He prides himself on obtaining optimal client outcomes, working to defy odds in some of the most plaintiff-friendly jurisdictions across the country.\u0026nbsp; Ryan's recent work includes defending clients in environmental and regulatory citizen suits, dozens of product liability and wrongful death actions, medical device cases related to surgical mesh products, commercial litigation in the private equity and real estate industries, and construction, transportation and other products litigation\u0026nbsp;cases involving catastrophic injuries suffered in workplace and automotive settings.\u003c/p\u003e\n\u003cp\u003eRyan has considerable experience in all stages of litigation, having taken or defended hundreds of depositions and managed countless cases through difficult discovery tracks, motion practice, mediation, trial and appeals.\u0026nbsp; He is routinely called upon to help defend clients in some of their most high-stakes litigation involving sensitive client information and sympathetic plaintiffs in environmental and regulatory compliance, wrongful death, traumatic brain injury and disfigurement cases.\u0026nbsp; Ryan regularly works with in-house counsel to develop strategy, discovery and case management plans from the early stages of litigation through trial.\u0026nbsp; Ryan is particularly skilled in\u0026nbsp;the development, presentation and defense of company witnesses in deposition and trial testimony.\u0026nbsp; He\u0026nbsp;is also a skilled writer and oral advocate, with a wide range of success in new and developing areas of the law.\u003c/p\u003e","slug":"ryan-kearney","email":"rkearney@kslaw.com","phone":null,"matters":null,"taggings":{"tags":[],"meta_tags":[]},"expertise":[{"id":74,"guid":"74.capabilities","index":0,"source":"capabilities"},{"id":764,"guid":"764.smart_tags","index":1,"source":"smartTags"},{"id":16,"guid":"16.capabilities","index":2,"source":"capabilities"},{"id":17,"guid":"17.capabilities","index":3,"source":"capabilities"},{"id":3,"guid":"3.capabilities","index":4,"source":"capabilities"},{"id":21,"guid":"21.capabilities","index":5,"source":"capabilities"},{"id":5,"guid":"5.capabilities","index":6,"source":"capabilities"},{"id":761,"guid":"761.smart_tags","index":7,"source":"smartTags"},{"id":71,"guid":"71.capabilities","index":8,"source":"capabilities"},{"id":984,"guid":"984.smart_tags","index":9,"source":"smartTags"},{"id":1114,"guid":"1114.smart_tags","index":10,"source":"smartTags"},{"id":1205,"guid":"1205.smart_tags","index":11,"source":"smartTags"}],"is_active":true,"last_name":"Kearney","nick_name":"Ryan","clerkships":[],"first_name":"Ryan","title_rank":9999,"updated_by":202,"law_schools":[{"id":722,"meta":{"degree":"J.D.","honors":"","is_law_school":"1","graduation_date":"2012-01-01 00:00:00"},"order":1,"pin_order":null,"pin_expiration":null}],"middle_name":"T.","name_suffix":"","recognitions":null,"linked_in_url":null,"seodescription":null,"primary_title_id":14,"translated_fields":{"en":{"bio":"\u003cp\u003eRyan Kearney is a seasoned litigator and trial lawyer with extensive experience in environmental and regulatory compliance, climate change and adaptation, product liability,\u0026nbsp;personal injury and commercial litigation, including mass tort and class action defense in the oil \u0026amp; gas, tobacco, consumer product, medical device, construction, private equity, real estate and transportation industries.[[--readmore--]]\u003c/p\u003e\n\u003cp\u003eRyan is a dedicated advocate for his clients, investing in creative strategies with a results-driven approach that has achieved nine complete defense verdicts for his trial teams in the last seven\u0026nbsp;years, in addition to dozens of favorable resolutions and outright dismissals pre-trial.\u0026nbsp; He prides himself on obtaining optimal client outcomes, working to defy odds in some of the most plaintiff-friendly jurisdictions across the country.\u0026nbsp; Ryan's recent work includes defending clients in environmental and regulatory citizen suits, dozens of product liability and wrongful death actions, medical device cases related to surgical mesh products, commercial litigation in the private equity and real estate industries, and construction, transportation and other products litigation\u0026nbsp;cases involving catastrophic injuries suffered in workplace and automotive settings.\u003c/p\u003e\n\u003cp\u003eRyan has considerable experience in all stages of litigation, having taken or defended hundreds of depositions and managed countless cases through difficult discovery tracks, motion practice, mediation, trial and appeals.\u0026nbsp; He is routinely called upon to help defend clients in some of their most high-stakes litigation involving sensitive client information and sympathetic plaintiffs in environmental and regulatory compliance, wrongful death, traumatic brain injury and disfigurement cases.\u0026nbsp; Ryan regularly works with in-house counsel to develop strategy, discovery and case management plans from the early stages of litigation through trial.\u0026nbsp; Ryan is particularly skilled in\u0026nbsp;the development, presentation and defense of company witnesses in deposition and trial testimony.\u0026nbsp; He\u0026nbsp;is also a skilled writer and oral advocate, with a wide range of success in new and developing areas of the law.\u003c/p\u003e"},"locales":["en"]},"secondary_title_id":null,"upload_assignments":{"headshot":[{"id":5838}]},"capability_group_id":3},"created_at":"2026-01-02T15:57:05.000Z","updated_at":"2026-01-02T15:57:05.000Z","searchable_text":"Kearney{{ FIELD }}Ryan Kearney is a seasoned litigator and trial lawyer with extensive experience in environmental and regulatory compliance, climate change and adaptation, product liability, personal injury and commercial litigation, including mass tort and class action defense in the oil \u0026amp; gas, tobacco, consumer product, medical device, construction, private equity, real estate and transportation industries.\nRyan is a dedicated advocate for his clients, investing in creative strategies with a results-driven approach that has achieved nine complete defense verdicts for his trial teams in the last seven years, in addition to dozens of favorable resolutions and outright dismissals pre-trial.  He prides himself on obtaining optimal client outcomes, working to defy odds in some of the most plaintiff-friendly jurisdictions across the country.  Ryan's recent work includes defending clients in environmental and regulatory citizen suits, dozens of product liability and wrongful death actions, medical device cases related to surgical mesh products, commercial litigation in the private equity and real estate industries, and construction, transportation and other products litigation cases involving catastrophic injuries suffered in workplace and automotive settings.\nRyan has considerable experience in all stages of litigation, having taken or defended hundreds of depositions and managed countless cases through difficult discovery tracks, motion practice, mediation, trial and appeals.  He is routinely called upon to help defend clients in some of their most high-stakes litigation involving sensitive client information and sympathetic plaintiffs in environmental and regulatory compliance, wrongful death, traumatic brain injury and disfigurement cases.  Ryan regularly works with in-house counsel to develop strategy, discovery and case management plans from the early stages of litigation through trial.  Ryan is particularly skilled in the development, presentation and defense of company witnesses in deposition and trial testimony.  He is also a skilled writer and oral advocate, with a wide range of success in new and developing areas of the law. Counsel Lehigh University  Fordham University Fordham University School of Law U.S. District Court for the Eastern District of New York U.S. District Court for the Southern District of New York U.S. District Court for the District of New Jersey U.S. District Court for the District of Colorado Florida Georgia New Jersey Nevada New York","searchable_name":"Ryan T. Kearney","is_active":true,"featured":null,"publish_date":null,"expiration_date":null,"blog_featured":null,"published_by":202,"capability_group_featured":null,"home_page_featured":null},{"id":426774,"version":1,"owner_type":"Person","owner_id":5576,"payload":{"bio":"\u003cp\u003eNicholas\u0026rsquo;s practice focuses on corporate internal investigations, defense of corporations and individuals in government investigations, white-collar criminal defense, and related complex civil litigation in state and federal court.\u0026nbsp; His experience includes defending companies and individuals in investigations and enforcement actions by various House and Senate committees, the Department of Justice, the U.S. Securities and Exchange Commission (SEC), Public Company Accounting Oversight Board (PCAOB), the Internal Revenue Service (IRS), state attorneys general, and other federal, state, and local agencies.\u0026nbsp; He has experience across a range of industries, including financial services, consumer retail, higher education, technology, healthcare, and life sciences.[[--readmore--]]\u003c/p\u003e\n\u003cp\u003eNicholas\u0026rsquo;s mix of white-collar and civil experience enables him to coordinate cohesive responses for clients facing multiple investigatory, litigation, and public relations issues that often arise in crisis or bet-the-company situations.\u0026nbsp; In addition, Nicholas provides compliance, risk-assessment, and crisis-management advice to companies.\u003c/p\u003e\n\u003cp\u003ePrior to joining King \u0026amp; Spalding, Nicholas worked in another global law firm's state and local tax practice where he advised clients in all stages of tax controversy beginning at audit all the way through litigation and appeal.\u0026nbsp; His multi-state tax experience includes resolving controversies involving corporate income, sales and use, gross receipts, and property tax matters.\u003c/p\u003e","slug":"nicholas-kump","email":"nkump@kslaw.com","phone":null,"matters":null,"taggings":{"tags":[],"meta_tags":[]},"expertise":[{"id":11,"guid":"11.capabilities","index":0,"source":"capabilities"},{"id":37,"guid":"37.capabilities","index":1,"source":"capabilities"},{"id":81,"guid":"81.capabilities","index":2,"source":"capabilities"},{"id":687,"guid":"687.smart_tags","index":3,"source":"smartTags"},{"id":18,"guid":"18.capabilities","index":4,"source":"capabilities"},{"id":1153,"guid":"1153.smart_tags","index":5,"source":"smartTags"},{"id":1241,"guid":"1241.smart_tags","index":6,"source":"smartTags"},{"id":109,"guid":"109.capabilities","index":7,"source":"capabilities"},{"id":21,"guid":"21.capabilities","index":8,"source":"capabilities"},{"id":103,"guid":"103.capabilities","index":9,"source":"capabilities"},{"id":24,"guid":"24.capabilities","index":10,"source":"capabilities"},{"id":107,"guid":"107.capabilities","index":11,"source":"capabilities"},{"id":1261,"guid":"1261.smart_tags","index":12,"source":"smartTags"}],"is_active":true,"last_name":"Kump","nick_name":"Nicholas","clerkships":[{"name":"Judicial Clerk, Sheila K. Oberto, U.S. District Court for the Eastern District of California","years_held":"2018 - 2019"}],"first_name":"Nicholas","title_rank":9999,"updated_by":35,"law_schools":[{"id":2402,"meta":{"degree":"J.D.","honors":"Order of the Coif, First in Class","is_law_school":1,"graduation_date":null},"order":1,"pin_order":null,"pin_expiration":null}],"middle_name":"J.","name_suffix":"","recognitions":null,"linked_in_url":null,"seodescription":null,"primary_title_id":75,"translated_fields":{"en":{"bio":"\u003cp\u003eNicholas\u0026rsquo;s practice focuses on corporate internal investigations, defense of corporations and individuals in government investigations, white-collar criminal defense, and related complex civil litigation in state and federal court.\u0026nbsp; His experience includes defending companies and individuals in investigations and enforcement actions by various House and Senate committees, the Department of Justice, the U.S. Securities and Exchange Commission (SEC), Public Company Accounting Oversight Board (PCAOB), the Internal Revenue Service (IRS), state attorneys general, and other federal, state, and local agencies.\u0026nbsp; He has experience across a range of industries, including financial services, consumer retail, higher education, technology, healthcare, and life sciences.[[--readmore--]]\u003c/p\u003e\n\u003cp\u003eNicholas\u0026rsquo;s mix of white-collar and civil experience enables him to coordinate cohesive responses for clients facing multiple investigatory, litigation, and public relations issues that often arise in crisis or bet-the-company situations.\u0026nbsp; In addition, Nicholas provides compliance, risk-assessment, and crisis-management advice to companies.\u003c/p\u003e\n\u003cp\u003ePrior to joining King \u0026amp; Spalding, Nicholas worked in another global law firm's state and local tax practice where he advised clients in all stages of tax controversy beginning at audit all the way through litigation and appeal.\u0026nbsp; His multi-state tax experience includes resolving controversies involving corporate income, sales and use, gross receipts, and property tax matters.\u003c/p\u003e"},"locales":["en"]},"secondary_title_id":null,"upload_assignments":{"headshot":[{"id":7102}]},"capability_group_id":2},"created_at":"2025-05-26T04:56:42.000Z","updated_at":"2025-05-26T04:56:42.000Z","searchable_text":"Kump{{ FIELD }}Nicholas’s practice focuses on corporate internal investigations, defense of corporations and individuals in government investigations, white-collar criminal defense, and related complex civil litigation in state and federal court.  His experience includes defending companies and individuals in investigations and enforcement actions by various House and Senate committees, the Department of Justice, the U.S. Securities and Exchange Commission (SEC), Public Company Accounting Oversight Board (PCAOB), the Internal Revenue Service (IRS), state attorneys general, and other federal, state, and local agencies.  He has experience across a range of industries, including financial services, consumer retail, higher education, technology, healthcare, and life sciences.\nNicholas’s mix of white-collar and civil experience enables him to coordinate cohesive responses for clients facing multiple investigatory, litigation, and public relations issues that often arise in crisis or bet-the-company situations.  In addition, Nicholas provides compliance, risk-assessment, and crisis-management advice to companies.\nPrior to joining King \u0026amp; Spalding, Nicholas worked in another global law firm's state and local tax practice where he advised clients in all stages of tax controversy beginning at audit all the way through litigation and appeal.  His multi-state tax experience includes resolving controversies involving corporate income, sales and use, gross receipts, and property tax matters. Senior Associate University of Southern California USC Gould School of Law University of the Pacific McGeorge School of Law California Judicial Clerk, Sheila K. Oberto, U.S. District Court for the Eastern District of California","searchable_name":"Nicholas J. Kump","is_active":true,"featured":null,"publish_date":null,"expiration_date":null,"blog_featured":null,"published_by":35,"capability_group_featured":null,"home_page_featured":null},{"id":442330,"version":1,"owner_type":"Person","owner_id":336,"payload":{"bio":"\u003cp\u003eDeborah Kremer joined King \u0026amp; Spalding in 2000 as an attorney with the E-Discovery practice and leads document reviews for the firm\u0026rsquo;s clients.\u0026nbsp; She has extensive experience in pre-trial discovery in mass tort litigation, including the representation of manufacturers of pharmaceutical and tobacco products.\u0026nbsp; She has developed particular expertise in managing cost-efficient electronic discovery in large-scale, multi-jurisdiction litigation.\u0026nbsp;\u003c/p\u003e\n\u003cp\u003e\u0026nbsp;\u003c/p\u003e","slug":"deborah-kremer","email":"dkremer@kslaw.com","phone":null,"matters":["\u003cp\u003eCoordinating all aspects of discovery in defense of several manufacturers in nationwide products liability litigation, including drafting responses to document requests/interrogatories, developing document collection scope statements, drafting document retention analyses, identifying key custodians, collecting hard copy and electronic documents, reviewing documents for responsiveness, privilege and confidentiality, producing responsive documents and providing \u0026ldquo;defensive needs\u0026rdquo; support to merits counsel.\u003c/p\u003e","\u003cp\u003eTraining and supervising up to 30 attorneys in pharmaceutical litigation. \u0026nbsp;\u003c/p\u003e","\u003cp\u003eTraining and managing a review team in pharmaceutical product liability litigation and supervising their review activities which included drafting deficiency letters and medical record review of over 5,000 plaintiffs.\u003c/p\u003e","\u003cp\u003eAssisting a \u003cem\u003eFortune \u003c/em\u003e50 pharmaceutical manufacturer involved in nationwide litigation defend challenges to privilege assertions made on over 3,000 documents, including the preparation of affidavits for client witnesses and documents for \u003cem\u003ein-camera\u003c/em\u003e review by the court.\u0026nbsp;\u003c/p\u003e","\u003cp\u003eCoordinating the collection of hard copy and electronic documents with client IT departments and outside vendors and identified document review populations through document search and analysis.\u003c/p\u003e","\u003cp\u003eCoordinating electronic analysis of voluminous paper document collection to identify duplicate documents for consistent identification of privileged and significant documents.\u003c/p\u003e","\u003cp\u003ePreparing budgets, project proposals and status reports for clients concerning document collections, reviews and productions.\u003c/p\u003e","\u003cp\u003eCoordinating and drafting responses to discovery requests in smoking and health litigation in connection with King \u0026amp; Spalding\u0026rsquo;s role as national discovery counsel for a cigarette manufacturer.\u003c/p\u003e","\u003cp\u003e\u003cstrong\u003eLitigation Technology Experience\u003c/strong\u003e\u003cbr /\u003eThrough her significant involvement in training and supervising attorney review teams, as well as her experience collecting, processing and producing documents, Mrs. Kremer regularly participates in the selection and supervision of vendors.\u0026nbsp; She also has experience drafting and developing review team plans and protocols.\u0026nbsp; She has extensive knowledge and experience of document review and litigation support systems including Applied Discovery\u0026rsquo;s Online Review Application (ORA), CaseCentral, Concordance, Introspect, IPro, Microsoft Access, Microsoft Excel, Relativity, Ringtail and Summation iBlaze.\u003c/p\u003e"],"taggings":{"tags":[],"meta_tags":[]},"expertise":[{"id":7,"guid":"7.capabilities","index":0,"source":"capabilities"},{"id":21,"guid":"21.capabilities","index":1,"source":"capabilities"},{"id":17,"guid":"17.capabilities","index":2,"source":"capabilities"},{"id":16,"guid":"16.capabilities","index":3,"source":"capabilities"},{"id":103,"guid":"103.capabilities","index":4,"source":"capabilities"},{"id":74,"guid":"74.capabilities","index":5,"source":"capabilities"}],"is_active":true,"last_name":"Kremer","nick_name":"Deborah","clerkships":[{"name":"Law Clerk, The Honorable Dick Greco Jr., Florida","years_held":"1997"}],"first_name":"Deborah","title_rank":9999,"updated_by":109,"law_schools":[{"id":1910,"meta":{"degree":"J.D.","honors":"magna cum laude","is_law_school":1,"graduation_date":"1997-01-01 00:00:00 UTC"},"order":1,"pin_order":null,"pin_expiration":null}],"middle_name":"L.","name_suffix":"","recognitions":null,"linked_in_url":null,"seodescription":null,"primary_title_id":84,"translated_fields":{"en":{"bio":"\u003cp\u003eDeborah Kremer joined King \u0026amp; Spalding in 2000 as an attorney with the E-Discovery practice and leads document reviews for the firm\u0026rsquo;s clients.\u0026nbsp; She has extensive experience in pre-trial discovery in mass tort litigation, including the representation of manufacturers of pharmaceutical and tobacco products.\u0026nbsp; She has developed particular expertise in managing cost-efficient electronic discovery in large-scale, multi-jurisdiction litigation.\u0026nbsp;\u003c/p\u003e\n\u003cp\u003e\u0026nbsp;\u003c/p\u003e","matters":["\u003cp\u003eCoordinating all aspects of discovery in defense of several manufacturers in nationwide products liability litigation, including drafting responses to document requests/interrogatories, developing document collection scope statements, drafting document retention analyses, identifying key custodians, collecting hard copy and electronic documents, reviewing documents for responsiveness, privilege and confidentiality, producing responsive documents and providing \u0026ldquo;defensive needs\u0026rdquo; support to merits counsel.\u003c/p\u003e","\u003cp\u003eTraining and supervising up to 30 attorneys in pharmaceutical litigation. \u0026nbsp;\u003c/p\u003e","\u003cp\u003eTraining and managing a review team in pharmaceutical product liability litigation and supervising their review activities which included drafting deficiency letters and medical record review of over 5,000 plaintiffs.\u003c/p\u003e","\u003cp\u003eAssisting a \u003cem\u003eFortune \u003c/em\u003e50 pharmaceutical manufacturer involved in nationwide litigation defend challenges to privilege assertions made on over 3,000 documents, including the preparation of affidavits for client witnesses and documents for \u003cem\u003ein-camera\u003c/em\u003e review by the court.\u0026nbsp;\u003c/p\u003e","\u003cp\u003eCoordinating the collection of hard copy and electronic documents with client IT departments and outside vendors and identified document review populations through document search and analysis.\u003c/p\u003e","\u003cp\u003eCoordinating electronic analysis of voluminous paper document collection to identify duplicate documents for consistent identification of privileged and significant documents.\u003c/p\u003e","\u003cp\u003ePreparing budgets, project proposals and status reports for clients concerning document collections, reviews and productions.\u003c/p\u003e","\u003cp\u003eCoordinating and drafting responses to discovery requests in smoking and health litigation in connection with King \u0026amp; Spalding\u0026rsquo;s role as national discovery counsel for a cigarette manufacturer.\u003c/p\u003e","\u003cp\u003e\u003cstrong\u003eLitigation Technology Experience\u003c/strong\u003e\u003cbr /\u003eThrough her significant involvement in training and supervising attorney review teams, as well as her experience collecting, processing and producing documents, Mrs. Kremer regularly participates in the selection and supervision of vendors.\u0026nbsp; She also has experience drafting and developing review team plans and protocols.\u0026nbsp; She has extensive knowledge and experience of document review and litigation support systems including Applied Discovery\u0026rsquo;s Online Review Application (ORA), CaseCentral, Concordance, Introspect, IPro, Microsoft Access, Microsoft Excel, Relativity, Ringtail and Summation iBlaze.\u003c/p\u003e"]},"locales":["en"]},"secondary_title_id":null,"upload_assignments":{"headshot":[{"id":4247}]},"capability_group_id":3},"created_at":"2025-11-05T05:02:31.000Z","updated_at":"2025-11-05T05:02:31.000Z","searchable_text":"Kremer{{ FIELD }}Coordinating all aspects of discovery in defense of several manufacturers in nationwide products liability litigation, including drafting responses to document requests/interrogatories, developing document collection scope statements, drafting document retention analyses, identifying key custodians, collecting hard copy and electronic documents, reviewing documents for responsiveness, privilege and confidentiality, producing responsive documents and providing “defensive needs” support to merits counsel.{{ FIELD }}Training and supervising up to 30 attorneys in pharmaceutical litigation.  {{ FIELD }}Training and managing a review team in pharmaceutical product liability litigation and supervising their review activities which included drafting deficiency letters and medical record review of over 5,000 plaintiffs.{{ FIELD }}Assisting a Fortune 50 pharmaceutical manufacturer involved in nationwide litigation defend challenges to privilege assertions made on over 3,000 documents, including the preparation of affidavits for client witnesses and documents for in-camera review by the court. {{ FIELD }}Coordinating the collection of hard copy and electronic documents with client IT departments and outside vendors and identified document review populations through document search and analysis.{{ FIELD }}Coordinating electronic analysis of voluminous paper document collection to identify duplicate documents for consistent identification of privileged and significant documents.{{ FIELD }}Preparing budgets, project proposals and status reports for clients concerning document collections, reviews and productions.{{ FIELD }}Coordinating and drafting responses to discovery requests in smoking and health litigation in connection with King \u0026amp; Spalding’s role as national discovery counsel for a cigarette manufacturer.{{ FIELD }}Litigation Technology ExperienceThrough her significant involvement in training and supervising attorney review teams, as well as her experience collecting, processing and producing documents, Mrs. Kremer regularly participates in the selection and supervision of vendors.  She also has experience drafting and developing review team plans and protocols.  She has extensive knowledge and experience of document review and litigation support systems including Applied Discovery’s Online Review Application (ORA), CaseCentral, Concordance, Introspect, IPro, Microsoft Access, Microsoft Excel, Relativity, Ringtail and Summation iBlaze.{{ FIELD }}Deborah Kremer joined King \u0026amp; Spalding in 2000 as an attorney with the E-Discovery practice and leads document reviews for the firm’s clients.  She has extensive experience in pre-trial discovery in mass tort litigation, including the representation of manufacturers of pharmaceutical and tobacco products.  She has developed particular expertise in managing cost-efficient electronic discovery in large-scale, multi-jurisdiction litigation. \n  Senior Attorney Stetson University Stetson University College of Law Stetson University Stetson University College of Law Georgia State  Bar of Georgia Law Clerk, The Honorable Dick Greco Jr., Florida Coordinating all aspects of discovery in defense of several manufacturers in nationwide products liability litigation, including drafting responses to document requests/interrogatories, developing document collection scope statements, drafting document retention analyses, identifying key custodians, collecting hard copy and electronic documents, reviewing documents for responsiveness, privilege and confidentiality, producing responsive documents and providing “defensive needs” support to merits counsel. Training and supervising up to 30 attorneys in pharmaceutical litigation.   Training and managing a review team in pharmaceutical product liability litigation and supervising their review activities which included drafting deficiency letters and medical record review of over 5,000 plaintiffs. Assisting a Fortune 50 pharmaceutical manufacturer involved in nationwide litigation defend challenges to privilege assertions made on over 3,000 documents, including the preparation of affidavits for client witnesses and documents for in-camera review by the court.  Coordinating the collection of hard copy and electronic documents with client IT departments and outside vendors and identified document review populations through document search and analysis. Coordinating electronic analysis of voluminous paper document collection to identify duplicate documents for consistent identification of privileged and significant documents. Preparing budgets, project proposals and status reports for clients concerning document collections, reviews and productions. Coordinating and drafting responses to discovery requests in smoking and health litigation in connection with King \u0026amp; Spalding’s role as national discovery counsel for a cigarette manufacturer. Litigation Technology ExperienceThrough her significant involvement in training and supervising attorney review teams, as well as her experience collecting, processing and producing documents, Mrs. Kremer regularly participates in the selection and supervision of vendors.  She also has experience drafting and developing review team plans and protocols.  She has extensive knowledge and experience of document review and litigation support systems including Applied Discovery’s Online Review Application (ORA), CaseCentral, Concordance, Introspect, IPro, Microsoft Access, Microsoft Excel, Relativity, Ringtail and Summation iBlaze.","searchable_name":"Deborah L. Kremer","is_active":true,"featured":null,"publish_date":null,"expiration_date":null,"blog_featured":null,"published_by":109,"capability_group_featured":null,"home_page_featured":null}]}}